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ABSTRACT 
 
Facile construction of synthetically and medicinally significant optically active 
molecular architectures from simple and readily available materials via catalytic 
enantioselective cascade processes is the cental goal in organic synthesis. Toward this 
end, my Ph. D. work focuses on the development of novel organocatalytic asymmetric 
cascade reactions and their application in the synthesis of versatile molecular structures. 
vi 
 
A novel amine catalyzed decarboxylative enantioselective Diels–Alder reaction 
between aldehydes and readily available coumarin-3-carboxylic acids as dienophiles via 
dienamine catalysis has been realized. Notably, the decarboxylation facilitates the release 
of the catalyst in the Diels–Alder reaction adducts and achieves high reaction efficiency 
in terms of reaction time, yield and enantio- and diastereo-selectivity. Furthermore, the 
Diels–Alder adducts are smoothly transformed into optically active bridged tricyclic 
benzopyrans by a novel but unexpected 'one-pot' protocol of LiAlH4 or NaBH4 mediated 
reduction and subsequent acid (workup) catalyzed highly stereoselective cyclization. 
Moreover, the decarboxylative strategy is applied to the efficient 'one-pot' synthesis of 
aromatized xanthones by pyrrolidine catalyzed Diels–Alder reactions of enals and 
subsequent oxidation reaction using DDQ. 
In addition, we have designed and implemented an unprecedented amine-catalyzed 
[4+1] annulation reaction. The notable features of the process include a new conjugate 
addition-protonation-conjugate addition cascade sequence by employing readily available 
ynals and N-protected-2-aminophenols as reactants. The mild reaction protocol allows for 
a broad spectrum of ynals and 2-aminophenols to engage in the cascade sequence with 
high efficiency. Synthetically and biologically important benzoxazoles are created in 
one-pot operation.  
Finally, intermolecular enantioselective desymmetrization of p-quinols by urea 
catalyst mediated sulfa-Michael addition reactions has been developed to furnish the 
corresponding products in good yields and moderate to good enantioselectivities as single 
diastereomers. 
 
vii 
 
  
Table of Contents 
ABSTRACT ........................................................................................................................ v 
List of Schemes ................................................................................................................... x 
List of Figures .................................................................................................................. xiii 
List of Tables ................................................................................................................... xiv 
List of Abbrevations ......................................................................................................... xv 
Chapter 1 Development of Organocatalysis ....................................................................... 1 
1.1 Introduction to Chiral Amine Catalysis .................................................................... 1 
1.1.1 Enamine Catalysis .............................................................................................. 1 
1.1.2 Diels–Alder Reactions via Enamine Catalysis ................................................... 4 
1.1.2.1 Inverse-Electron-Demanding [4+2] Reactions ............................................ 4 
1.1.2.2 [4+2] Reactions with Enamine-Activated Dienes ....................................... 6 
1.1.3 Iminium Catalysis ............................................................................................... 7 
1.1.3.1 Iminium-Activated Diels–Alder Reactions ................................................. 8 
1.1.3.2 Iminium-Activated Sequential [4+2] Reactions .......................................... 9 
1.1.3.3 Iminium-Activated [3+2] Reactions .......................................................... 12 
1.1.3.4 Iminium-Activated Sequential [3+2] Reactions ........................................ 14 
1.1.4 Dienamine Catalysis ......................................................................................... 16 
1.1.4.1 γ-Functionalization via Dienamine Catalysis ............................................ 17 
1.1.4.2 α-Functionalization via Dienamine Catalysis ............................................ 19 
1.1.4.3 Diels–Alder Reactions ............................................................................... 20 
1.1.4.4 Inverse-Electron-Demanding Diels–Alder Reactions ............................... 20 
1.1.4.5 [2+2] Reactions .......................................................................................... 22 
1.1.5 Trienamine Catalysis ........................................................................................ 24 
1.2 Chiral Thiourea Catalysis ........................................................................................ 25 
References ..................................................................................................................... 27 
Chapter 2 Enantioselective Decarboxylative Diels–Alder reactions ................................ 35 
2.1 Background ............................................................................................................. 35 
2.2 Research Design ...................................................................................................... 37 
viii 
 
2.3 Optimization of Reaction Conditions ...................................................................... 38 
2.4 Expansion of Substrate Scope ................................................................................. 41 
2.5 Discussion ............................................................................................................... 43 
Conclusion ..................................................................................................................... 45 
Experimental Section .................................................................................................... 45 
References ..................................................................................................................... 61 
Chapter 3 Construction of Chiral Bridged Tricyclic Benzopyrans................................... 64 
3.1 Background ............................................................................................................. 64 
3.2 Research Design ...................................................................................................... 65 
3.3 Scope Expansion ..................................................................................................... 66 
Conclusion ..................................................................................................................... 68 
Experimental Section .................................................................................................... 68 
References ..................................................................................................................... 75 
Chapter 4 Organocatalytic Casacde Synthesis of Xanthones ........................................... 77 
4.1 Background ............................................................................................................. 77 
4.2 Research Design ...................................................................................................... 79 
4.3 Optimization of Reaction Conditions ...................................................................... 80 
4.4 Expansion of Substrate Scope ................................................................................. 81 
Conclusion ..................................................................................................................... 82 
Experimental Section .................................................................................................... 83 
References ..................................................................................................................... 87 
Chapter 5 [4+1] Annulations of Alkynals via an Organocatalytic Double Michael 
Cascade ............................................................................................................................. 89 
5.1 Background ............................................................................................................. 89 
5.2 Research Design ...................................................................................................... 90 
5.3 Optimization of Reaction Conditions ...................................................................... 92 
5.4 Expansion of Substrate Scope ................................................................................. 93 
5.5 Application .............................................................................................................. 95 
5.6 Discussion ............................................................................................................... 96 
Conclusion ..................................................................................................................... 99 
Experimental Section .................................................................................................... 99 
ix 
 
References ................................................................................................................... 113 
Chapter 6 Asymmetric Desymmetrization of p-Quinols ................................................ 117 
6.1 Background ........................................................................................................... 117 
6.2 Research Design .................................................................................................... 118 
6.3 Optimization of Reaction Conditions .................................................................... 120 
6.4 Expansion of Substrate Scope ............................................................................... 122 
Conclusion ................................................................................................................... 124 
Experimental Section .................................................................................................. 124 
References ................................................................................................................... 136 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
x 
 
List of Schemes 
Scheme 1.1 Enamine formation…………………………………………………………..1 
Scheme 1.2 (S)-proline catalyzed asymmetric aldolization………………………………2 
Scheme 1.3 Mechanism of (S)-proline catalyzed asymmetric aldolization………………2 
Scheme 1.4 (S)-proline catalyzed asymmetric Mannich reaction………………………...3 
Scheme 1.5 Organocatalytic hetero-Diels–Alder reaction………………………………..5 
Scheme 1.6 Aza-Diels–Alder reaction of N-sulfonyl-1-aza-1,3-butadienes……………...5 
Scheme 1.7 Dienamine formation from branched enones………………………………...6 
Scheme 1.8 Organocatalytic three-component Diels–Alder reaction…………………….6 
Scheme 1.9 Hetero-Diels–Alder reactions via enamine catalysis………………………...7 
Scheme 1.10 Iminium formation………………………………………………………….7 
Scheme 1.11 Diels–Alder reaction via iminium catalysis………………………………...8 
Scheme 1.12 Diels–Alder reactions of α,β-unsaturated ketone…………………………..9 
Scheme 1.13 Diels–Alder reaction of α-substituted acrolein……………….…………….9 
Scheme 1.14 Cascade Michael-aldol reaction…………………………………….……10 
Scheme 1.15 Expansion of [4+2] reactions of enals…………………………………….10 
Scheme 1.16 Oxa-Michael-Michael reaction of alkynal………………………………...11 
Scheme 1.17 Aza-Michael-aldol reactions………………………………………………11 
Scheme 18 Other [4+2] ractions of alkynal 47…………………………………………..12 
Scheme 1.19 [3+2] cycloaddition of nitrone 58…………………………………………12 
Scheme 1.20 [3+2] cycloaddition of azomethyne ylide…………………………………13 
Scheme 1.21 1,3-dipolar cycloaddition of azomethine imine…………………………...13 
Scheme 1.22 [3+2] Reactions of 2-mercapto-1-phenylethanone………………………..14 
xi 
 
Scheme 1.23 Cascade Michael-aldol reactions………………………………………….14 
Scheme 1.24 Cascade double Michael addition reactions………………………………15 
Scheme 1.25 Enantioselective domino Michael/aldol reaction…………………………15 
Scheme 1.26 One-step synthesis of hexahydrofuro[3,4-c]furane……………………….16 
Scheme 1.27 Dienamine formation from enals………………………………………….16 
Scheme 1.28 γ-Amination of α,β-unsaturated aldehyde………………………………...17 
Scheme 1.29 Synthesis of 86 via dienamine catalysis…………………………………..18 
Scheme 1.30 γ-Functionalization of α-branched enal…………………………………...18 
Scheme 1.31 Intramolecular Rauhut-Currier reaction…………………………………..19 
Scheme 1.32 Intermolecular Michael reaction via dienamine catalysis………………...20 
Scheme 1.33 Diels–Alder reaction via dienamine catalysis…………………………….20 
Scheme 1.34 Inverse-electron-demanding aza-Diels–Alder reactions………………….21 
Scheme 1.35 All-carbon-based Diels–Alder reaction………………………….………..21 
Scheme 1.36 Association of enal and nitroolefin with catalyst 105…………………….22 
Scheme 1.37 [2+2] cycloaddition reaction via dienamine catalysis…………………….22 
Scheme 1.38 Design of 15-catalyzed [2+2] cycloaddition reaction…………………….23 
Scheme 1.39 [2+2] cycloaddition reaction of α-branched nitroolefin…………………..23 
Scheme 1.40 Dienamine formation from enals………………………………………….24 
Scheme 1.41 Diels–Alder reactions of 3-olefinic oxindole……………………………..25 
Scheme 1.42 Diels–Alder reactions of cross-trienamines……………………………….25 
Scheme 1.43 Development of chiral thiourea catalysts…………………………………25 
Scheme 1.44 Quinine promoted sulfa-Michael addition reaction……………………….26 
Scheme 1.45 Chiral thiourea 120 catalyzed Michael addition reaction…………………27 
xii 
 
Scheme 1.46 Chiral thiourea 121 catalyzed Michael-aldol reactions…………………...27 
Scheme 2.1 Challenge in Diels–Alder reaction via dienamine catalysis………………..35 
Scheme 2.2 Hetero-Diels–Alder reaction of dienamine…………………………………36 
Scheme 2.3 Preparetion of intermediate 13……………………………………………...36 
Scheme 2.4 Diels–Alder reaction of chiral N-dienyl lactam…………………………….37 
Scheme 2.5 Design of decarboxylative Diels–Alder reactions………………………….38 
Scheme 2.6 Process for Diels–Alder reactions………………………………………….44 
Scheme 3.1 Two-step synthesis of bridged tricyclic benzopyran.....................................65 
Scheme 3.2 Sequence of transforming 1 to bridged tricyclic benzopyran 4....................66 
Scheme 4.1 Synthesis of xanthones 2 via C-H activation from imine…………….…….78 
Scheme 4.2 Synthesis of xanthones 4 via C-H activation from aldehyde……….………78 
Scheme 4.3 Oxidative double C-H carbonylation of diaryl ethers………………………79 
Scheme 4.4 Synthesis of xanthones via Diels–Alder reactions………………………….79 
Scheme 4.5 Design of 'one-pot' synthesis of xanthones…………………………………80 
Scheme 5.1 Proposed amine catalyzed [4+1] annulations………………………………91 
Scheme 5.2 Synthetic elaboration of [4+1] annulation products………………………..95 
Scheme 5.3 Rationalization of low enantioselectivity of chiral amine catalyzed [4+1] 
annulations……………………………………………………………………………….97 
Scheme 6.1 Design of thiourea catalyzed desymmetrization of p-quinols…………….119 
 
 
 
 
xiii 
 
List of Figures 
Figure 1.1 Secondary amine catalysts 8 and 9………………………………..…………..4 
Figure 1.2 Chiral catalysts 12 and 15……………………………………………………..5 
Figure 1.3 Organocatalysts 19 and 22…………………………………………………….6 
Figure 1.4 Organocatalysts 27, 30 and 34………………………………………………...8 
Figure 1.5 Organoatalysts……………………………………………………………...10 
Figure 1.6 Catalysts……………………………………………………………………..13 
Figure 1.7 Catalysts……………………………………………………………………..17 
Figure 1.8 Catalyst 108…………………………………………………….……………24 
Figure 2.1 Catalyst 7……………………………………………….……………………36 
Figure 2.2 X-Ray Structure of 21l………………………………………………………42 
Figure 2.3 Determination of relative stereochemistry of 21q..........................................43 
Figure 3.1 Bridged tricyclic benzopyran core unit A in natural products........................64 
Figure 3.2 X-Ray Structure of 4e……………………………………………………….68 
Figure 4.1 Natural products with xanthone core………………………………………..77 
Figure 6.1 Natural products with 4-hydroxycyclohexanone scaffold………………….117 
Figure 6.2 Chiral urea and thiourea catalysts…………………………………………..120 
Figure 6.3 X-ray structure of product 4………………………………………………..124 
 
 
 
 
 
xiv 
 
List of Tables 
Table 1.1 Michael addition reactions mediated by different catalysts……………………3 
Table 2.1 Optimization of reaction conditions…………………………………………..39 
Table 2.2 Scope of 1i catalyzed Diels–Alder reactions…………………………………41 
Table 3.1 Formation of 4 by 'one-pot' reduction-acid catalyzed cyclization of 1……….67 
Table 4.1 Optimization of reaction conditions…………………………………………..81 
Table 4.2 Scope of 'one-pot' synthesis of xanthones…………………………………….82 
Table 5.1 Optimization of reaction conditions…………………………………………..93 
Table 5.2 Scope of pyrrolidine catalyzed [4+1] annulation reactions…………………..94 
Table 5.3 Exploration of enantioselective [4+1] annulations…………………………...96 
Table 5.4 Addition sequence tests of [4+1] annulation reactions……………………….98 
Table 6.1 Optimization of reaction conditions…………………………………………121 
Table 6.2 Substrate scope expansion of organocatalytic sulfa-Michael addition 
reaction………………………………………………………………………………….123 
 
 
 
 
 
 
 
 
 
xv 
 
List of Abbrevations 
[α]D Specific Rotation at Wavelength of Sodium D Line 
Ac Acetyl 
aq. Aqueous
Ar Aromatic
Bn Benzyl 
Boc  t-Butoxycarbonyl
bp  Boilong Point
t-Bu  t-Butyl 
Bz  Benzoyl
c  Concentration
Cbz  Benzyloxycarbonyl
CDCl3  Deuterated Chloroform
δ  Chemical Shift
DCE  Dichloroethane
DCM  Dichloromethane
DMF  N,N-Dimethylformamide
DMSO  Dimethyl Sulfoxide
D2O  Deuterated Water
EDG  Electron Donating Group
ee  Enantiomeric Excess
eq.  equivalent
xvi 
 
EtOAc  Ethyl Acetate
EWG  Electron Withdrawing Group
g  Gram 
h  Hour 
HOMO  Highest Occupied Molecular Orbital
HPLC  High Performance Liquid Chromatography
HRMS  High Resolution Mass Spectrometry
Hz  Hertz 
Ј  Coupling Constant
λ  Wavelength
LUMO  Lowest Unoccupied Molecular Orbital
m-  Meta- 
Me  Methyl 
MeCN  Acetonitrile
Mg  Magnesium
mg  Milligram
min.  Minute 
mL  Milliliter
mp  Melting Point
Ms-  Methanesulfonyl
NMR  Nuclear Magnetic Resonance
o-  Ortho 
xvii 
 
p- Para- 
Ph  Phenyl 
PG  Protecting Group
ppm  Parts per Million
i-PrOH  Isopropyl Alcohol
rt  Room Temperature
TB(DM)S  tert-Butyldimethylsilyl
TBME  tert-Butylmethylether
TEA  Triethylamine
TES  Triethylsilyl
Tf  Trifluoromethanesulfonyl
TFA  Trifluoroacetic Acid
THF  Tetrahydrofuran
TLC Thin-Layer Chromatography
TMS Trimethylsilyl
Ts p-Toluenesulfonyl
μL Microliter
 
 
 
 
 
 
1 
 
Chapter 1 
Development of Organocatalysis 
 
1.1 Introduction to Chiral Amine Catalysis 
Organocatalysis has become an important and widely applied synthetic strategy after 
ten years of rapid development.1 In this context, chiral secondary amine2 catalyzed 
enantioselective reactions via enamine3 or iminium4 mode have conceptualized the field. 
Chiral primary amine catalytic model,5 phase transfer catalytic model,6 chiral Brønsted 
base catalytic model,7 chiral Brønsted acid catalytic model,8 H-bonding catalytic model,9 
and nucleophilic heterocyclic carbene catalytic model10 have been also developed soon 
after. In relation to my studies, chiral secondary amine catalysis and chiral thiourea 
catalysis are introduced in detail in this chapter. 
1.1.1 Enamine Catalysis 
Enamine activated aldehydes or ketones are generally suitable nucleophiles which 
can be applied in the α-functionalization of aldehydes or ketones via a HOMO-raising 
strategy (Scheme 1.1).3 
Scheme 1.1 Enamine formation 
 
2 
 
Inspired by the study that calss I aldolases mediate aldolization via enamine 
mechanism, Benjamin List and co-workers developed proline catalyzed asymmetric aldol 
reaction between acetone and a variety of aldehydes for the first time (Scheme 1.2).11  
Scheme 1.2 (S)-proline catalyzed asymmetric aldolization 
 
The mechanism of (S)-proline catalyzed asymmetric aldol reaction is shown in 
scheme 1.3. Iminium A, produced from dehydration between (S)-proline and acetone, is 
in equilibrium with enamine B. The nucleophilic enamine B can attack aldehyde 1 
enantioselectively to afford intermediate C. (S)-proline is regenerated upon hydrolysis of 
C and aldol product 2 is released at the same time. 
Scheme 1.3 Mechanism of (S)-proline catalyzed asymmetric aldolization 
 
The emamine catalysis can be extended to various kinds of reactions by replacing 
the electrophile 1 according to the mechanism of asymmetric aldolization via enamine 
catalysis (Scheme 1.3). For example, in-situ prepared imine was exposed to enamine B to 
produce Mannich product 5 in 50% yield and 94% ee (Scheme 1.4).12 
 
Scheme 1.4 (S)-proline catalyzed asymmetric Mannich reaction. 
 
List and co-workers also developed the first proline catalyzed Michael addition 
reaction between ketone 6 and nitroolefin 7 to give Michael product 10 in good yields 
and dr but only low ee (Table 1.1, entry 1).13  
Table 1.1 Michael addition reactions mediated by different catalysts 
O
Ph
NO2 Catalyst
O
NO2
Ph
+
6 7 10  
entry catalyst solvent yield (%)[a] dr
[b] ee 
(%)[c] 
1 (S)-proline DMSO 94 >20:1 23 
2[d] 8 CHCl3 95 >20:1 99 
3 9 i-PrOH 96 >20:1 97 
[a] Isolated yields. [b] Determined by 1H NMR. [c] Determined by HPLC. [d] 2,4-
dinitrobenzenesulfonic acid as additive. 
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The enantioselectivity of the Michael addition reaction was improved by utilizing 
respective chiral pyrrolidine-pyridine conjugate base catalyst14 or pyrrolidine 
sulfonamide (Figure 1.1)15 in 2004 (Table 1.1, entry 2 and 3). 
Figure 1.1 Secondary amine catalysts 8 and 9 
 
Other electrophiles involved α-functionalization reactions of carbonyl compounds 
via enamine catalysis were also developed to furnish the corresponding products in good 
yields and enantioselectivities.3 
1.1.2 Diels–Alder Reactions via Enamine Catalysis 
More importantly, chiral amine catalysis can be applied in the cascade processes for 
rapid synthesis of valuable optically active building blocks from readily available starting 
materials. Especially, the enamines produced from carbonyl compounds and chiral amine 
catalysts can participate in all kinds of Diels–Alder reactions designed for the facile 
construction of cyclic structures. 
1.1.2.1 Inverse-Electron-Demanding [4+2] Reactions 
It is envisioned that chiral enamines can participate in asymmetric hetero-Diels–
Alder reactions with β,γ-unsaturated α-ketoesters as electron-rich dienophiles. Jørgensen 
and co-workers found that the proposed organocatalytic inverse-electron-demanding 
hetero-Diels–Alder reaction was feasible to furnish the desired products 13 in good yields 
4 
 
and enantioselectivities as single diastereomers after oxidation (Scheme 1.5).16 It is 
noteworthy that silica is used for the regeneration of catalyst 12. 
 
Figure 1.2 Chiral catalysts 12 and 15 
 
Scheme 1.5 Organocatalytic hetero-Diels–Alder reaction 
 
Inspired by Jørgensen's ingenious design of oxy-Diels–Alder reactions between 
enamines and β,γ-unsaturated α-ketoesters, Chen and co-workers developed highly 
stereoselective inverse-electron-demand aza-Diels–Alder reactions of N-sulfonyl-1-aza-
1,3-butadienes and enamines to furnish the chiral piperidine derivatives 16 in good 
yields, diastereoselectivities and enantioselectivities (Scheme 1.6).17 
Scheme 1.6 Aza-Diels–Alder reaction of N-sulfonyl-1-aza-1,3-butadienes 
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1.1.2.2 [4+2] Reactions with Enamine-Activated Dienes 
Contrary to the inverse-electron-demanding Diels–Alder reactions employing 
enamine as dienophiles, Diels–Alder reactions of chiral 2-amino-1,3-dienes (Scheme 
1.7), in situ generated from α,β-unsaturated ketones and chiral amine catalysts have also 
been developed.18  
Scheme 1.7 Dienamine formation from branched enones 
 
High enantioselectivity for the Diels–Alder product was not achieved until 5-
dimethyl thiazolidinium-4-carboxylate (DMTC) was utilized to catalyze the domino 
Knoevenagel/Diels–Alder reactions in 2003.19  
Scheme 1.8 Organocatalytic three-component Diels–Alder reaction 
Figure 1.3 Organocatalysts 19 and 22 
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Highly substituted spiro[5,5]undecane-1,5,9-trione 20 was produced from enone 17, 
aldehydes 3, and 2,2-dimethyl-1,3-dioxane-4,6-dione 18 in 93% yield and 99% ee as a 
single diastereomer (Scheme 1.8). 
The strategy was extended to hetero-Diels–Alder reactions of enamine produced 
from enone 21 with O-nitroso20 or in situ prepared imine21 to produce enantiopure Diels–
Alder adducts in moderate yields (Scheme 1.9). 
Scheme 1.9 Hetero-Diels–Alder reactions via enamine catalysis 
 
1.1.3 Iminium Catalysis 
α,β-Unsaturated aldehydes or ketones can be activated by forming iminium ions 
with a chiral amine catalyst (Scheme 1.10). Correspondingly, iminium activated enals or 
enones are considered as electrophiles which can be utilized in the β-functionalization of 
enals or enones through a LUMO-lowering model. Compared to the corresponding α,β-
unsaturated aldehydes or ketones, the iminium ions are more prone to a nucleophilic 
attack. 
Scheme 1.10 Iminium formation 
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1.1.3.1 Iminium-Activated Diels–Alder Reactions 
The asymmetric iminium catalysis can be traced back to 1993.22 However, a more 
general platform for Diels–Alder reaction via iminium catalysis was established by 
MacMillan and co-workers in 2000 (Scheme 1.11).23  
Scheme 1.11 Diels–Alder reaction via iminium catalysis 
 
Diels–Alder products were obtained from various dienes and α,β-unsaturated 
aldehydes in good yields and enantioselectivities. Low diastereoselectivities were 
observed for the Diels–Alder reaction employing cyclopentadiene. The 
diastereoselectivities were greatly improved when cyclopentadiene was replaced with 
other dienes. 
Figure 1.4 Organocatalysts 27, 30 and 34 
 
MacMillan and co-workers were surprised to find that racemic cycloaddition adduct 
was obtained when α,β-unsaturated aldehyde was replaced with α,β-unsaturated ketone.24 
Upon optimizing reaction condition, 2-(5-methylfuryl)-derived imidazolidinone 30 was 
identified as an effective promoter for the Diels–Alder reactions of α,β-unsaturated 
ketone 29 to afford the desired product 31 in 89% yield, 25:1 dr and 90% ee (Scheme 
1.12).  
8 
 
Scheme 1.12 Diels–Alder reactions of α,β-unsaturated ketone 
 
Although great results had been achieved in secondary amine mediated Diels–Alder 
reactions, it was found that α-substituted acroleins were difficult to be activated by 
secondary amines. However, primary amine catalyst 34 was effective for promoting the 
asymmetric Diels–Alder reaction between α-substituted acrolein and diene to produce the 
desired product 35 in 99% yield and 90% ee (Scheme 1.13).25 
 
Scheme 1.13 Diels–Alder reaction of α-substituted acrolein 
 
1.1.3.2 Iminium-Activated Sequential [4+2] Reactions 
Different from the concerted asymmetric Diels–Alder reactions leading to chiral 
cyclohexene structures, sequential [4+2] reactions of α, β-unsaturated aldehydes 
affording benzene-fused cyclic building blocks have also been reported. 
Initially, 2-mercaptobenzaldehyde 36 was employed to react with enal 26 to afford 
thiochromene 38 in 85% yield and 94% ee (Scheme 1.14).26 
 
9 
 
 
Scheme 1.14 Cascade Michael-aldol reaction 
 
Figure 1.5 Organoatalysts 
N
H OTMS
Ar
Ar
Ar = 3,5-(CF3)2C6H3
37
N
H OTES
Ph
Ph
41
N
H OTBS
Ph
Ph
48
N
H
Ph Ph
52
 
The extension of this strategy was soon realized by replacing 2-
mercaptobenzaldehyde 36 to 2-mercaptoacetophenone,27 salicylaldehydes,28 2-amino 
benzaldehydes,29 2-(nitromethyl)benzaldehyde,30 2-((E)-2-nitrovinyl)phenol31 for the 
sequential [4+2] reaction to furnish the desired products in moderate to good yields with 
high enantio- and diastereoselectivities as shown in scheme 1.15. 
 
Scheme 1.15 Expansion of [4+2] reactions of enals 
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It is noteworthy that an additional Michal-aldol condensation occurs after the [4+2] 
reaction between 26 and 2-((E)-2-nitrovinyl)phenol 45 via iminium catalysis to produce 
complex structure 46 with excellent results (Scheme 1.15).31 
2-((E)-2-Nitrovinyl)phenol 45 was also found to engage in a sequential [4+2] 
reaction with alkynal 47 via iminium catalysis efficiently (Scheme 1.16).32 The process 
proceeded smoothly to produce synthetically and biologically significant chiral 4H-
chromene 49 in high yield (97%) and with excellent enantioselectivity (>99%). 
Scheme 1.16 Oxa-Michael-Michael reaction of alkynalsw 
 
Quinolines 51 and chiral 1,4-dihydroquinolines 53 were obtained from the 
sequential [4+2] reactions of protected 2-amino acetophenones 50 and alkynals 47 
divergently by the choice of different protecting groups in 50 (Scheme 1.17).33 
Scheme 1.17 Aza-Michael-aldol reactions 
 
The sequential [4+2] reactions of alkynal 47 were extended to (2-hydroxy-phenyl)-
2-oxoacetates 5434 and salicylimines 5635 to produce optically active 4H-chromenes 55 
with a quaternary chiral center and 4-amino-4H-chromenes 57 respectively (Scheme 
1.18). 
Scheme 18 Other [4+2] ractions of alkynal 47 
 
1.1.3.3 Iminium-Activated [3+2] Reactions 
Iminium-activated [3+2] cycloaddition reactions leading to five-membered ring 
architectures have also been initially developed by MacMillan and co-workers by simply 
replacing diene in the previously reported Diels–Alder reaction23 to nitrone 58 to provide 
isoxazolidine 60 in 98% yield, 94:6 dr and 94% ee (Scheme 1.19) in 2000.36 Highly 
chemo- and enantioselective organocatalytic three-component reaction of enals with in 
situ generated nitrones from N-arylhydroxylamines and aldehydes was reported.37 
Scheme 1.19 [3+2] cycloaddition of nitrone 58 
 
Similarly, polysubstituted pyrrolidines can also be prepared from [3+2] 
cycloaddition reactions of azomethine ylides through MacMillan's LUMO-lowering 
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strategy by iminium activation. The [3+2] reaction between azomethine ylide 61 and enal 
26 proceeds smoothly to furnish stereoisomerically pure highly functionalized 
polysubstituted pyrrolidine 63 in good yield with complete regioselectivity and excellent 
diastereo- and enantioselectivity (Scheme 1.20).38 
Scheme 1.20 [3+2] cycloaddition of azomethyne ylide 
 
Figure 1.6 Catalysts 
 
Extension of iminium-activated [3+2] cycloadditions to azomethine imines with α,β-
unsaturated aldehydes39 and cyclic enones40 has been realized by Chen and co-workers.  
Scheme 1.21 1,3-dipolar cycloaddition of azomethine imine 
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Notably, the multifunctional cinchona alkaloid derived primary amine catalyst was 
found to promote the [3+2] cycloaddition reaction of azomethine imine 64 and enone 65 
efficiently to give tricyclic compound 67 in 89% yield and 90% ee (Scheme 1.21). 
1.1.3.4 Iminium-Activated Sequential [3+2] Reactions 
Similar to enantioselective sequential [4+2] cascade reactions employing reactants 
bearing 1,4-nucleophilic-electrophilic sites, sequential [3+2] reactions of reactants with 
1,3-nucleophilic-electrophilic sites have been implemented to furnish five-membered ring 
structures. 
Scheme 1.22 [3+2] Reactions of 2-mercapto-1-phenylethanone 
 
The first highly enantioselective sequential [3+2] reaction between 2-mercapto-1-
phenylethanone 68 and enal 69 was reported to produce highly functionalized 
tetrahydrothiophenes 70 or 71 depending on the additives used (Scheme 1.22).41 
Scheme 1.23 Cascade Michael-aldol reactions 
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As a continuation of our cascade reactions, we identified that aldehyde 72 bearing a 
malonate unit was suitable reactant with compatible 1,3-nucleophilic and electrophilic 
functionalities for [3+2] reactions (Scheme 1.23).42 
It was proposed that undesirable side reactions could be minimized by using bulky 
and enolizable malonates and organocatalyst 41. The assumption was proved to be 
feasible by the sequential [3+2] reaction between enal 26 and aldehyde 72 to produce the 
desired product 73 in 81% yield and 93% ee. 
Scheme 1.24 Cascade double Michael addition reactions 
 
In addition the [3+2] reaction employing aldehyde 72 through Michael-aldol 
sequence, a novel [3+2] cascade reaction of α,β-unsaturated ester 74 with enal 75 via 
Michael-Michael sequence was also conducted (Scheme 1.24). The advantage of the 
novel system is that the [3+2] adduct with three stereogenic centers can be formed. The 
desired tetrasubstituted cyclopentane 76 was obtained.43 
Scheme 1.25 Enantioselective domino Michael/aldol reaction 
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The similar strategy was applied to [3+2] cascade reaction between 1,2-
cyclohexadione 77 and the α,β-unsaturated aldehyde 26 to provide the bicyclic molecule 
78 in 77% yield and 96% ee (Scheme 1.25).44 
Interestingly, alcohol dihydroxyacetone dimer 79 can also be utilized in the [3+2] 
reaction of α,β-unsaturated aldehyde 26 and an additional hemiacetalization to provide 
hexahydrofuro[3,4-c]furane 80 in excellent yield and with diastereo- and 
enantioselectivity (Scheme 1.26).45 
Scheme 1.26 One-step synthesis of hexahydrofuro[3,4-c]furane 
 
1.1.4 Dienamine Catalysis 
Jørgensen and co-workers unexpectedly found that more than 50% of 37 was 
present in the form of dienamine rather than iminium when it was mixed with 2-pentenal 
69 in C6D6 (Scheme 1.27).46  
Scheme 1.27 Dienamine formation from enals 
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In fact, the expected iminium could not be detected in the same experiment by using 
1H NMR. Different from the dienamine produced from branched enones for α- and β-
functionalization, the dienamine produced from enals can be used to achieve the goal of 
γ-functionalization. 
1.1.4.1 γ-Functionalization via Dienamine Catalysis 
The resulting dienamine formed from 2-pentenal 69 and catalyst 37 was then 
exposed to electrophilic diethyl azodicarboxylate 81.46 The electronic property of 
electrophilic enal 58 was inverted to act as a nucleophile for the reaction with diethyl 
azodicarboxylate 81 to afford adduct 82 in moderate yield and ee (Scheme 1.28). 
Scheme 1.28 γ-Amination of α,β-unsaturated aldehyde 
 
Figure 1.7 Catalysts 
 
Aldol reaction of dienamine was also conducted in an aldol-oxo-Michael-
hemiacetlization-oxidation sequence to produce valuable building block 86 in 58% yield 
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and 97% de (Scheme 1.29).47 The resulting adduct 86 was then applied to the synthesis of 
α-tocopherol. 
Scheme 1.29 Synthesis of 86 via dienamine catalysis 
 
The relative low yields observed for the γ-functionalization of enals may be 
attributed to the competing reactions for α-functionalization of enals. It is assumed that 
the regioselectivity of the reaction can be improved by blocking the α-position of enals.  
Scheme 1.30 γ-Functionalization of α-branched enal 
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The assumption was proved to be feasible by employing α-branched enal 87 for the 
dienamine mediated reaction with 88 through an SN1 pathway to furnish adduct 91 in 
84% yield and 95% ee (Scheme 1.30).48 
The same research group extended the strategy to the reactions of β-substituted 
cyclohexenone derivatives with nitroalkenes49 and α-keto esters50. 
1.1.4.2 α-Functionalization via Dienamine Catalysis 
Similarly, α-functionalization of α,β-unsaturated aldehydes can be selectively 
realized by blocking the γ-position of the enals with an additional substituent. An 
intramolecular Rauhut-Currier reaction was designed with γ-disubstituted enal 92 to give 
product 93 in 73% yield and 96% ee (Scheme 1.31).51  
Scheme 1.31 Intramolecular Rauhut-Currier reaction 
 
It is controversial to conclude that the selective attack from α-position is attributed 
to the blocking of γ-position of enal 92. The prevention of attack from γ-position may 
also result from the high transition-state energy for the formation of four-membered ring. 
The controversy was excluded by the intermolecular reaction between γ-disubstituted 
enal 94 and nitroolefin 7 via dienamine catalysis (Scheme 1.32).52 Furthermore, 
dienamine-activated selective α-alkylation of enals was also developed.53 
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Scheme 1.32 Intermolecular Michael reaction via dienamine catalysis 
 
1.1.4.3 Diels–Alder Reactions 
It is soon realized that the dienamines produced from enals can also be applied as 
dienes for Diels–Alder reactions through similar strategy as dienamines formed from 
branched enones as discussed previously. Hong and co-workers reported that Diels–
Alder reaction between 3-methylbut-2-enal 96 and α,β-unsaturated aldehyde 97 can be 
achieved to afford [4+2] adduct 98 in 72% yield and 95% ee (Scheme 1.33).54  
Scheme 1.33 Diels–Alder reaction via dienamine catalysis 
 
Intramolecular Diels–Alder reactions between dienamine unit and α,β-unsaturated 
aldehyde unit were also investigated to prepare bicyclic structures.55 In addition, reactive 
quinones were utilized as dienophiles in the Diels–Alder reactions with dienamines.56 
1.1.4.4 Inverse-Electron-Demanding Diels–Alder Reactions 
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Electron-rich dienamine can also be employed as dienophiles in inverse-electron-
demanding Diels–Alder reactions when it is exposed to suitable electron-deficient dienes. 
Chen and co-workers found that inverse-electron-demanding aza-Diels–Alder reactions 
of electron-deficient N-sulfonyl 1-aza-1,3-butadienes with aliphatic α,β-unsaturated 
aldehydes proceeded smoothly with exclusive α regioselectivity. Chiral piperidine 
derivatives bearing several functional groups were constructed with moderate to good 
yields (66-95%), moderate E/Z ratios and excellent enantioselectivities (97-99% ee) 
(Scheme 1.34).57 
Scheme 1.34 Inverse-electron-demanding aza-Diels–Alder reactions 
 
 
Scheme 1.35 All-carbon-based Diels–Alder reaction 
 
It is proposed that the regioselectivity of enals in the inverse-electron-demanding 
Diels–Alder reactions can be inverted by employing γ-unsubstituted crotonaldehyde. 
Indeed, β,γ-selectivity was observed when the strategy was extended to all-carbon-based 
asymmetric inverse-electron-demand Diels–Alder reactions with crotonaldehyde. 
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Cyclohexene derivatives with substantial substitution diversity were obtained with high 
diastereo- and enantioselectivities (up to 99% ee, d.r. up to 95:5) (Scheme 1.35).58 
1.1.4.5 [2+2] Reactions 
It was conceived that β,γ-selectivity can also be achieved with γ-substituted enals by 
utilizing appropriate bifunctional catalyst in dienamine catalysis.59 Bifunctional catalyst 
105 activates enal with secondary amine unit and nitroolefin 7 with H-bonding unit 
simultaneously. It is believed that the substrates are positioned within a suitable distance 
for β,γ-selectivity from the computational studies (Scheme 1.36). 
Scheme 1.36 Association of enal and nitroolefin with catalyst 105 
 
Scheme 1.37 [2+2] cycloaddition reaction via dienamine catalysis 
 
The desired [2+2] cycloaddition product 106 was obtained in 86% yield, >20:1 dr 
and >99% ee (Scheme 1.37). It is noteworthy that HCONEt2 was added to improve the 
solubility of the catalyst and H2O was added to accelerate the reaction. 
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Scheme 1.38 Design of 15-catalyzed [2+2] cycloaddition reaction 
 
An alternative strategy for the β,γ-selectivity with simple secondary amine catalysts 
was also developed by favorable formation of hemiacetals to stabilize the desired [2+2] 
adducts (Scheme 1.38).60 Special α-branched nitroolefin 107 was utilized to produce 
intermediates 109 and 110 resulting from α- and β,γ-selectivity respectively. It is 
assumed that intermediate 109 will be transformed to 110 for the formation of stable 
hemiacetal 112. The cycloadduct 112 was obtained in 86% yield and 91% ee as expected 
under dienamine with catalyst 15 and H-bonding catalysis with 108 (Scheme 1.39). 
 
Scheme 1.39 [2+2] Cycloaddition reaction of α-branched nitroolefin 
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Figure 1.8 Catalyst 108 
 
1.1.5 Trienamine Catalysis 
Naturally, extension of the enals in the dienamine catalysis to 2,4-hexadienals will 
provide an access to trienamines which can be used as reactive dienes for Diels–Alder 
reactions (Scheme 1.40). 
Scheme 1.40 Dienamine formation from enals 
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Chen and Jøgensen applied the strategy to the reaction with nitroolefins,61 (Z)-
olefinic azlactones,62 3-olefinic oxindoles,63 olefinic cyanoacetates.63 Spirocyclic 
products 114 can be prepared from the Diels–Alder reactions of trienamines and 3-
olefinic oxindoles in excellent results (Scheme 1.41).63 Indole-2,3-quinodimethane 
strategy was also applied in the Diels–Alder reactions via trienamine catalysis.64 Besides, 
it was found that trienamine could also be prepared from 2,4-dienones.65 
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Scheme 1.41 Diels–Alder reactions of 3-olefinic oxindole 
 
More importantly, reactions of cross-trienamines and 3-olefinic oxindoles for the 
formation bridged bicyclic adducts 117 were also introduced (Scheme 1.42).66 
Scheme 1.42 Diels–Alder reactions of cross-trienamines 
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1.2 Chiral Thiourea Catalysis 
Scheme 1.43 Development of chiral thiourea catalysts 
 
Chiral thiourea catalysts, especially cinchona alkaloid-derived thiourea catalysts 
have been widely utilized to mediate various transformations to furnish optically active 
building blocks. It has been proved that cost effective cinchona alkaloid-derived thiourea 
catalysts are efficient bifunctional catalysts for a number classes of reactions. The 
development of the catalysts can be traced back to 30 years ago (Scheme 1.43). 
As early as 1981, it was found that sulfa-Michael addition reaction between PhSH 
and enone 122 proceeded smoothly to give product 123 in 57% ee (Scheme 1.44).67 
Scheme 1.44 Quinine promoted sulfa-Michael addition reaction 
 
Quinine was considered to be bifunctional catalyst which activated PhSH with 
tertiary amine unit and enone 122 with OH group through H-bonding simultaneously. It 
was also assumed that the enantioselectivity could be improved by providing bifunctional 
catalyst with more basic unit and stronger H-bonding donating ability.  
It is well known that OH group on aromatic ring is more acidic than corresponding 
secondary alcohols. Thus, the phenolic OH group can be acted as stronger H-bonding 
donor. A novel bifunctional catalyst 119 was prepared by 6ˊ-demethylation of cinchona 
alkaloid-derivative. Excellent enentioselectivities were observed in 119-mediated 
asymmetric Baylis-Hillman reactions.68 
Thiourea 108 was identified as efficient H-bonding donor in Diels–Alder 
reactions.69 Therefore, 3,5-(CF3)2-C6H3 attached thiourea unit was connected to chiral 
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scaffold soon afterwards. In 2003, chiral thiourea catalyst 120 was first employed as 
functional catalyst for Michael addition reaction between diethyl malonate and 
nitroolefin 7 to produce adduct 124 in 86% yield and 93% ee (Scheme 1.45).70 
Scheme 1.45 Chiral thiourea 120 catalyzed Michael addition reaction 
 
Superior cinchona alkaloid-derived thiourea catalysts bearing more basic unit and 
rigid conformation were also developed in 2005.71 The inexpensive catalysts have been 
proved to be efficient in numerous kinds of reactions. It is worth noting that chiral 
thiourea catalyst 121 was employed in the cascade reaction between 2-
mercaptobenzaldehyde 36 and α,β-unsaturated oxazolidinone 125 to give cyclic product 
126 with excellent results (Scheme 1.46).72 
Scheme 1.46 Chiral thiourea 121 catalyzed Michael-aldol reactions 
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 Chapter 2 
Enantioselective Decarboxylative Diels–Alder reactions 
 
2.1 Background 
While impressive progress has been made in the Diels–Alder reactions employing 
dienamines as dienes as discussed in Chapter 1, the scope of the strategy is still limited. 
In these processes, it has to realy on utilizing reactive dienophiles bearing α-proton and 
strong withdrawing groups to achieve the goal of catalyst regeneration. Otherwise, Diels–
Alder reaction between dienamine 3 and dienophile can only provide catalyst ‘trapped’ 
tertiary amine intermediate 4 (Scheme 2.1). Intermediate 4 may decompose to produce 
enal 2 through a retro-Diels–Alder sequence or be separated as a stable compound. 
Scheme 2.1 Challenge in Diels–Alder reaction via dienamine catalysis 
 
Rawal and co-workers applied secondary amine tethered diene 5 to hetero-Diels–
Alder reactions with aldehydes 6.1 Although the secondary amine could be removed by 
the addition of acetal chloride, one equivalent of secondary amine was still needed 
(Scheme 2.2). 
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Scheme 2.2 Hetero-Diels–Alder reaction of dienamine 
 
Figure 2.1 Catalyst 7 
 
Jørgensen and co-workers separated the catalyst attached Diels–Alder intermediate 
13 in 35% yield with 2:1 dr in 2006 (Scheme 2.3).2 It was found that elimination of the 
catalyst 11 from the tertiary amine was difficult. 
Scheme 2.3 Preparetion of intermediate 13 
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Formation of catalyst attached Diels–Alder intermediate was confirmed by Beller 
and co-workers in the asymmetric Diels–Alder reaction between chiral N-dienyl lactam 
16 and maleic anhydride to give chiral lactam attached product 17 in 73% yield (Scheme 
2.4).3 Besides, reactive dienophiles are necessary in the Diels–Alder reactions with 
dienamines. For example, control experiment of employing coumarin as dienophile in the 
Diels–Alder reactions with dienamines was unsuccessful. Thus, the scope of Diels–Alder 
reactions via dienamine catalysis is rather limited.  
 
 
Scheme 2.4 Diels–Alder reaction of chiral N-dienyl lactam 
 
2.2 Research Design 
In view of the challenges, a novel catalytic enantioselective Diels–Alder reaction of 
readily available coumarin-3-carboxylic acids with aldehydes is designed (Scheme 2.5).4 
The carboxylic moiety not only enhances the reactivitity of coumarins as dienophiles, but 
also facilitates the release of the amine catalyst.5 Different from the reported studies in 
aminocatalytic Diels–Alder reactions where the dienophiles contain prerequisite α-
hydrogen, essential for the release of the amine catalyst,6 a novel catalyst release mode 
via a decarboxylation is uncovered. Importantly, the decarboxylation assisted release of 
the catalyst enables the Diels–Alder reaction to proceed efficiently (short reaction times 
and high yields) under mild reaction conditions, and highly enantio- and diastereo-
selectively. 
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Scheme 2.5 Design of decarboxylative Diels–Alder reactions 
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Diels–Alder reactions between in-situ formed dienamine 3 and various dienophiles 
lead to catalyst attached tertiary amine adducts. Regeneration of the catalyst is prevented 
due to the difficulty in eliminating the catalyst from tertiary amine structure. Although 
the release of catalyst was realized by employing special dienophiles bearing strong 
electron-withdrawn group and α-proton, the efficiency of the reaction was generally  
low. We envisioned that the release of the catalyst can be facilitated by utilizing 
dienophile 18 bearing α-carboxylic acid group (Scheme 2.5). Elimination of the catalyst 
from tertiary amine 19 could be facilitated by decarboxylation. In addition, substrate 
scope of the reaction can be expanded greatly by using temporarily activated weak 
dienophiles. 
2.3 Optimization of Reaction Conditions 
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Diels–Alder reaction of 3-methyl-2-butenal 2a with coumarin-3-carboxylic acid 
20a was selected as the model reaction (Table 2.1).  
Table 2.1 Optimization of Reaction Conditions.[a]  
 
Entry Cat. Additive Solvent t (h) Yield (%)[b] ee (%)[c] 
1 1a none DCE 10 81 19 
2 1b none DCE 0.5 97 54 
3 1c none DCE 0.5 94 74 
4 1d none DCE 1 95 81 
5 1e none DCE 2/3 92 10 
6 1f none DCE 3 87 0 
7 1g none DCE 3 94 61 
8 1h none DCE 10 85 89 
9 1i none DCE 10 96 92 
10 1i none toluene 4 94 39 
11[d] 1i none TME 4 90 29 
12 1i none THF 4 91 40 
13 1i none EtOAc 4 85 54 
14 1i none CH3CN 4 81 69 
15 1i none DMSO 6 80 76 
16 1i none CH2Cl2 7 97 88 
17 1i none CHCl3 7 95 94 
18 1i none MeOH 7 79 87 
19 1i PhCO2H CHCl3 10 91 91 
20 1i AcOH CHCl3 10 90 90 
21 1i DIPEA CHCl3 10 81 86 
22 1i 2,6-lutidine CHCl3 10 83 91 
23[e] 1i none CHCl3 24 89 92 
[a] Conditions: unless specified, see Experimental Section. [b] Isolated yields. [c] 
Determined by chiral HPLC. [d] TME = tert-butyl methyl ether [e] 0 °C. 
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The model reaction between 3-methyl-2-butenal 2a and coumarin-3-carboxylic acid 
20a in the presence of chiral amine 1a in dichloroethane (DCE) at rt was carried out. To 
our delight, the process took place regioselectively to give the desired product 21a in 
81% yield but with poor enantioselectivity (entry 1). The catalyst was facilely released 
via the designed decarboxylation and a quick process (10 h) was observed. Encouraged 
by the outcomes, we screened more chiral amine promoters (Table 1). It was found that 
the catalyst played significant roles in governing reaction efficiency and 
enantioselectivity. The TMS catalyst 1b[10] was more efficient for promoting the Diels–
Alder reaction by affording 97% yield of 21a in just 30 min with 54% ee (entry 2).  
More bulky diarylprolinol silyl catalysts (e.g., 1c: TES and 1d: TBS, entries 3-4) further 
enhanced the enantioselectivity of the product formed. Nonetheless, we were surprised to 
find that ee values of 21a decreased dramatically when more hindered catalysts 1e and 1f 
bearing CF3 groups on the aromatic ring were employed (entries 5 and 6). We speculated 
that the decrease of ee values might be attributed to the strong electron-withdrawing 
properties of CF3 groups. The assumption was verified by the studies of the catalysts 1g 
and 1h, where the CF3 moiety was replaced by methyl group (entries 7 and 8).  Among 
the catalysts probed, catalyst 1i was proved to be the best. In this case, 96% yield of 21a 
with 92% ee in 10 h was achieved (entry 9). In addition to catalysts, solvents were also 
critical to the enantioselectivity of the reaction. In general, non-polar solvents such as 
toluene, TME, and THF led to low ee values (entries 10-12), while slightly improved 
ones were observed with polar EtOAc, CH3CN, DMSO and MeOH (entries 13-15 and 
18). Chlorinated solvents CH2Cl2 and CHCl3 were good choice for the reaction (entries 
16 and 17). Acidic or basic additives were detrimental (entries 19-22). Finally, no benefit 
was gained when the reaction was conducted at a decreased temperature (entry 23). 
2.4 Expansion of Substrate Scope  
Table 2.2 Scope of IX Catalyzed Diels–Alder Reactions.[a]  
 
Entry R1, R2 R3, R4 21 Yield (%)[b] ee (%)[c] 
1 Me, H H, H 21a 95 94 
2 Me, H Me, H 21b 97 92 
3 Me, H H, Me 21c 93 90 
4 Me, H MeO, H 21d 89 94 
5 Me, H Br, H 21e 97 90 
6 Me, H H, Br 21f 94 93 
7 Me, H H, NO2 21g 92 91 
8 H, H MeO, H 21h 85 92 
9 Ph, H H, H 21i 91 94 
10 Ph, H Br, H 21j 89 92 
11 3-MeC6H4, H Br, H 21k 93 92 
12 4-MeC6H4, H Br, H 21l 91 90 
13 4-FC6H4, H Me, H 21m 87 92 
14 3-BrC6H4, H Br, H 21n 83 92 
15 3,4-Cl2C6H3, H Br, H 21o 88 94 
16[d] H, Me Br, H 21p 81 90 
17[e] H, Me H, NO2 21q 91 92 
18[f] H, Et H, NO2 21r 89 90 
19[g] H, Pr H, NO2 21s 90 94 
[a] Conditions: unless specified, see Experimental Section. [b] Isolated yields. [c] 
Determined by chiral HPLC. [d] 15 h, 15:1 dr (determined by 1H NMR of crude product). 
[e] 15 h, 14:1 dr. [f] 15 h, 21:1 dr. [g] 15 h, 13:1 dr. 
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With the optimized reaction conditions in hand for this 1i-catalyzed Diels–Alder 
reaction, we probed its scope (Table 2.2). The results reveal that the process can be 
applied for both substrates with a broad generality. Uniformly high yields (81-95%) and 
high ee (90-94%) are obtained for all cases studied. 
Investigation of the structural effect of courmarin-3-carboxylic acids 20 indicates 
that the electronic effect is very limited. The aromatic ring bearing electron-neutral 
(entries 1 and 9), -donating (entries 2-4, 8, and 13), -withdrawing (entries 5-7, 10-12 and 
14-19) groups with different substitution patterns are well tolerated in the reaction and 
lead to structurally diverse compounds 21.  With respect to enals 2, significant structural 
variations are explored. It appears that in addition to 3-methyl-2-butenal 2a (entries 1-7), 
linear aldehydes (entries 8 and 16-19) and branched β,β'-disubstituted aldehydes (entries 
9-15) can serve as effective dienes in the Diels–Alder reactions. In case of linear enals 
(entries 16-19), two new stereogenetic centers are formed with high enantio- and 
diastereoselectivities. 
The absolute configuration of 21l was determined by X-ray crystallographic 
analysis (Figure 2.2). 
Figure 2.2 X-Ray Structure of 21l 
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The relative stereochemistry of compound 21q with trans geometry is determined 
by 1D shaped pulses NOE experiments (Figure 2.3). Irradiation of the methyl group 
protons leads to the appearance and inversion of the peaks of H proton at 3.85 ppm. 
Similarly, the peaks of protons on the methyl group appear and are inverted when the H 
at 3.85 ppm was irradiated. The relative configurations of 21q, 21r and 21s are 
determined analogously. 
Figure 2.3 Determination of relative stereochemistry of 21q 
 
 
2.5 Discussion 
The proposed configuration in 22 originates from Re face attack of the dienamine 3 
by coumarin 3-carboxylic acids 20 in an exo-manner (Scheme 2.6).  This is because the 
Si face blocked by the bulky side chain of the catalyst and the interaction between “N” 
atom of the catalyst and the carboxylic acid moiety in 20 dictates an exo-addition of the 
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dienophile.[6e] Furthermore, the steric hindrance between the bulky side chain of the 
catalyst and the lactone moiety in 22 leads to the cis configuration of the catalyst and the 
carboxylic acid. This geometry enables the facile decarboxylation to release the catalyst 
and products 21 with the observed configuration. In addition, the carboxylic acid 
enhances the reactivity of the coumarins as dienophiles. Indeed, without it, no desired 
Diels–Alder adduct was observed between coumarin and 2a under the identical reaction 
conditions. In a controlled study, the carboxylic acid is masked as an ethyl ester, the 
Diels–Alder reaction with 2a in the presence of 100 mol% catalyst 1i occurred, but 
afforded a catalyst 'entrapped' product in 53% yield based on 1H NMR analysis. 
However, the product was decomposed on silica gel column during purification to give 
back to coumarin-3-carboxylate ethyl ester starting material via a retro-Diels–Alder 
process. 
Scheme 2.6 Process for Diels–Alder reactions 
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Conclusion 
A novel amine catalyzed decarboxylative enantioselective Diels–Alder reaction 
between aldehydes and readily available coumarin-3-carboxylic acids as dienophiles has 
been implemented to construct the chiral precursors. The decarboxylation facilitates the 
release of the catalyst and achieves high reaction efficiency in terms of reaction time, 
yield and enantio- and diastereo-selectivity. 
Experimental Section 
General Information (This part is applied to all the sections) 
Commercially available reagents were used as received without further purification 
unless otherwise specified. Merck 60 silica gel was used for column chromatography, 
and Whatman silica gel plates with fluorescence F254 were used for thin-layer 
chromatography (TLC) analysis. 1H and 13C NMR spectra were recorded on Bruker 
Avance 500 or 300. Data for 1H NMR are reported as follows: chemical shift (ppm), and 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, dd = double doublet, ddd = 
double double doublet, td = triple doublet, dt = double triplet, m = multiplet, bs = broad 
signal). Data for 13C NMR are reported as ppm. Catalysts 1a, 1e and 1g were purchased 
from Sigma Aldrich. Catalysts 1b,7 1c,7 1d,8 1f,8 1h8 and 1i8 were prepared according to 
the literature procedures. Substrates 2a, 2b, 2i, 2j, 2k and 20a were purchased from 
Sigma Aldrich. 
Preparation and Spectroscopic Data for Substrates 2c-2h 
Substrates 2c-2h were prepared according to literature procedure.9 
 (E)-3-Phenylbut-2-enal (2c) 
The title compound was obtained in 73% yield for three steps as light yellow oil. 1H 
NMR (300 MHz, CDCl3) δ (ppm) 10.18 (d, J = 7.8 Hz, 1H), 7.56-7.51 (m, 2H), 7.44-7.40 
(m, 3H), 6.39 (dd, J = 8.1 Hz, 1.2 Hz, 1H), 2.57 (d, J = 1.2 Hz, 3H); 13C NMR (75.5 
MHz, CDCl3) δ (ppm) 191.2, 157.6, 140.5, 130.0, 128.7, 127.2, 126.2, 16.3. 
 
(E)-3-(m-Tolyl)but-2-enal (2d) 
The title compound was obtained in 65% yield for three steps as yellow oil. 1H 
NMR (300 MHz, CDCl3) δ (ppm) 10.17 (d, J = 7.8 Hz, 1H), 7.35-7.24 (m, 4H), 6.38 (dd, 
J = 8.1 Hz, 1.5 Hz, 1H), 2.56 (d, J = 1.2 Hz, 3H), 2.39 (s, 3H); 13C NMR (75.5 MHz, 
CDCl3) δ (ppm) 191.3, 157.9, 140.5, 138.4, 130.8, 128.6, 127.1, 126.9, 123.4, 21.4, 16.4. 
 
(E)-3-(p-Tolyl)but-2-enal (2e) 
The title compound was obtained in 61% yield for three steps as yellow oil. 1H 
NMR (500 MHz, CDCl3) δ (ppm) 10.16 (d, J = 8.0 Hz, 1H), 7.45 (d, J = 7.5 Hz, 2H), 
7.22 (d, J = 8.0 Hz, 2H), 6.39 (d, J = 8.0 Hz, 1H), 2.54 (s, 3H), 2.38 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ (ppm) 191.2, 157.5, 140.5, 137.4, 129.4, 126.4, 126.1, 21.2, 16.1. 
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 (E)-3-(4-Fluorophenyl)but-2-enal (2f) 
The title compound was obtained in 52% yield for three steps as yellow oil. 1H 
NMR (300 MHz, CDCl3) δ (ppm) 10.16 (d, J = 7.8 Hz, 1H), 7.57-7.52 (m, 2H), 7.13-7.08 
(m, 2H), 6.35 (dd, J = 7.8 Hz, 0.9 Hz, 1H), 2.56 (d, J = 0.9 Hz, 3H); 13C NMR (75.5 
MHz, CDCl3) δ (ppm) 191.1, 156.3, 128.2, 128.1, 127.0, 115.9, 115.6, 16.3. 
 
(E)-3-(3-Bromophenyl)but-2-enal (2g) 
The title compound was obtained in 47% yield for three steps as yellow solid. M. P. 
70-71 ºC; 1H NMR (300 MHz, CDCl3) δ (ppm) 10.17 (d, J = 7.8 Hz, 1H), 7.67 (t, J = 1.5 
Hz, 1H), 7.55 (d, J = 8.1 Hz, 1H), 7.46 (d, J = 8.1 Hz, 1H), 7.29 (t, J = 7.8 Hz, 1H), 6.35 
(dd, J = 7.8 Hz, 1.2 Hz, 1H), 2.55 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 190.9, 
155.7, 142.7, 132.8, 130.2, 129.3, 127.9, 124.8, 122.9, 16.4. 
 
(E)-3-(3,4-Dichlorophenyl)but-2-enal (2h) 
The title compound was obtained in 58% yield for three steps as yellow solid. M. P. 
65-66 ºC; 1H NMR (300 MHz, CDCl3) δ (ppm) 10.17 (d, J = 7.5 Hz, 1H), 7.62 (d, J = 2.1 
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Hz, 1H), 7.49 (d, J = 8.4 Hz, 1H), 7.37 (dd, J = 8.4 Hz, 2.1 Hz, 1H), 6.35 (d, J = 7.5 Hz, 
1H), 2.54 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 191.7, 154.4, 140.4, 134.1, 
133.1, 130.7, 128.2, 127.9, 125.4, 16.2. 
Preparation and Spectroscopic Data for Substrates 20b-20g 
Substrates 20b-20g were prepared according to literature procedure.10 
 
7-Methyl-2-oxo-2H-chromene-3-carboxylic acid (20b) 
The title compound was obtained in 81% yield as white solid. M. P. 200-201 ºC; 1H 
NMR (500 MHz, DMSO-d6) δ (ppm) 8.71 (s, 1H), 7.77 (d, J = 7.5 Hz, 1H), 7.26 (s, 1H), 
7.23 (d, J = 8.0 Hz, 1H), 2.43 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ (ppm) 164.1, 
156.9, 154.7, 148.6, 145.8, 129.9, 126.0, 116.9, 116.2, 115.6, 21.5. 
 
6-Methyl-2-oxo-2H-chromene-3-carboxylic acid (20c) 
The title compound was obtained in 85% yield as white solid. M. P. 165-166 ºC; 1H 
NMR (500 MHz, DMSO-d6) δ (ppm) 8.63 (s, 1H), 7.64 (s, 1H), 7.52 (d, J = 8.0 Hz, 1H), 
7.30 (d, J = 8.5 Hz, 1H), 2.35 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ (ppm) 164.1, 
157.0, 152.7, 148.3, 135.3, 134.2, 129.7, 118.3, 117.4, 116.0, 20.3. 
 
7-Methoxy-2-oxo-2H-chromene-3-carboxylic acid (20d) 
48 
 
The title compound was obtained in 80% yield as white solid. M. P. 193-194 ºC; 1H 
NMR (500 MHz, DMSO-d6) δ (ppm) 8.71 (s, 1H), 7.82 (d, J = 8.5 Hz, 1H), 7.02 (s, 1H), 
6.99 (d, J = 8.5 Hz, 1H), 3.88 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ (ppm) 164.7, 
164.2, 157.2, 156.9, 149.1, 131.6, 113.8, 113.3, 111.6, 100.3, 56.3. 
 
7-Bromo-2-oxo-2H-chromene-3-carboxylic acid (20e) 
The title compound was obtained in 87% yield as white solid. M. P. 205-206 ºC; 1H 
NMR (500 MHz, DMSO-d6) δ (ppm) 8.68 (s, 1H), 7.78 (d, J = 8.5 Hz, 1H), 7.66 (s, 1H), 
7.52 (d, J = 8.0 Hz, 1H); 13C NMR (125 MHz, DMSO-d6) δ (ppm) 163.8, 156.0, 154.8, 
147.8, 131.5, 128.0, 127.4, 119.2, 118.5, 117.3. 
 
6-Bromo-2-oxo-2H-chromene-3-carboxylic acid (20f) 
The title compound was obtained in 83% yield as white solid. M. P. 192-193 ºC; 1H 
NMR (500 MHz, DMSO-d6) δ (ppm) 8.68 (s, 1H), 8.15 (d, J = 1.5 Hz, 1H), 7.85 (dd, J = 
8.5 Hz, 2.0 Hz, 1H), 7.40 (d, J = 9.0 Hz, 1H); 13C NMR (125 MHz, DMSO-d6) δ (ppm) 
163.8, 156.1, 153.6, 147.0, 136.4, 132.0, 119.9, 119.5, 118.5, 116.3. 
 
6-Nitro-2-oxo-2H-chromene-3-carboxylic acid (20g) 
The title compound was obtained in 87% yield as light brown solid. M. P. 234-235 
ºC; 1H NMR (500 MHz, DMSO-d6) δ (ppm) 8.91 (d, J = 1.5 Hz, 1H), 8.89 (s, 1H), 8.49 
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(dd, J = 9.5 Hz, 2.0 Hz, 1H), 7.64 (d, J = 9.0 Hz, 1H); 13C NMR (125 MHz, DMSO-d6) δ 
(ppm) 163.5, 158.1, 155.4, 147.2, 143.6, 128.4, 126.0, 120.3, 118.4, 117.7. 
General Procedure for Diels–Alder Reactions 
To a mixture of coumarin-3-carboxylic acid 20a (0.023 g, 0.12 mmol) and catalyst 
1i (0.0094 g, 0.02 mmol) in 0.2 mL CHCl3 was added 2a (10 μL, 0.1 mmol). The reaction 
was stirred at room temperature until 2a was consumed completely (7 h). The mixture 
was applied to column chromatography directly and eluted with hexane and ethyl acetate 
to give 0.0202 g pure product 21a in 95% yield. The purified compound was used for 
characterization and chiral HPLC analysis. 
Physical and Spectroscopic Data for Diels–Alder Products 21a-21s 
 
(R)-9-Methyl-10,10a-dihydro-6H-benzo[c]chromen-6-one (21a) 
The title compound was obtained in 95% yield as white solid. M. P. 84-85 ºC; 
[α]D25 = -47.0° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.39 (dd, J = 5.4 Hz, 
3.6 Hz, 1H), 7.28-7.23 (m, 2H), 7.14 (dd, J = 8.4 Hz, 1.2 Hz, 1H), 7.06 (dd, J = 9.6 Hz, 
1.8 Hz, 1H), 6.06 (dd, J = 3.3 Hz, 1.5 Hz, 1H), 4.04 (dd, J = 17.7 Hz, 6.6 Hz, 1H), 2.80 
(dd, J = 17.1 Hz, 8.7 Hz, 1H), 2.39 (dd, J = 19.2 Hz, 17.4 Hz, 1H), 2.03 (s, 3H); 13C 
NMR (75.5 MHz, CDCl3) δ (ppm) 162.1, 150.5, 146.2, 138.8, 128.3, 126.1, 124.4, 123.3, 
120.7, 118.0, 117.2, 34.4, 32.1, 23.7. The ee was determined to be 94% by HPLC on 
Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 70 / 30, 0.5 mL/min-1, λ = 254 nm, tr 
(major) = 14.61 min, tr (minor) = 18.57 min. 
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 (R)-3,9-Dimethyl-10,10a-dihydro-6H-benzo[c]chromen-6-one (21b) 
The title compound was obtained in 97% yield as white solid. M. P. 96-97 ºC; 
[α]D25 = -67.8° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.38 (dd, J = 5.4 Hz, 
3.3 Hz, 1H), 7.12 (d, J = 7.8 Hz, 1H), 6.94 (d, J = 7.8 Hz, 1H), 6.88 (s, 1H), 6.05 (dd, J = 
3.6 Hz, 2.1 Hz, 1H), 3.99 (dd, J = 19.5 Hz, 7.8 Hz, 1H), 2.77 (dd, J = 17.1 Hz, 8.7 Hz, 
1H), 2.42-2.30 (m, 4H), 2.02 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 162.4, 
150.3, 146.1, 138.7, 138.6, 125.8, 125.2, 120.7, 120.2, 118.3, 117.6, 34.6, 31.9, 23.8, 
21.0. The ee was determined to be 92% by HPLC on Daicel Chiralpak AS-H (25 cm), 
Hexanes / IPA = 70 / 30, 0.4 mL/min-1, λ = 254 nm, tr (major) = 17.76 min, tr (minor) = 
61.27 min. 
 
(R)-2,9-Dimethyl-10,10a-dihydro-6H-benzo[c]chromen-6-one (21c) 
The title compound was obtained in 93% yield as white solid. M. P. 145-146 ºC; 
[α]D25 = -33.1° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.38 (t, J = 5.1 Hz, 
1H), 7.05 (d, J = 6.6 Hz, 2H), 6.95 (d, J = 8.7 Hz, 1H), 6.06 (s, 1H), 4.00 (dd, J = 19.5 
Hz, 7.2 Hz, 1H), 2.79 (dd, J = 17.1 Hz, 8.4 Hz, 1H), 2.41 (d, J = 19.2 Hz, 1H), 2.33 (s, 
3H), 2.03 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 162.4, 148.4, 146.1, 138.7, 
133.9, 128.9, 126.5, 122.9, 120.7, 118.3, 117.0, 34.5, 32.2, 23.8, 20.8. The ee was 
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determined to be 90% by HPLC on Daicel Chiralpak IC (25 cm), Hexanes / IPA = 85 / 
15, 0.5 mL/min-1, λ = 254 nm, tr (major) = 52.80 min, tr (minor) = 61.38 min. 
 
(R)-3-Methoxy-9-methyl-10,10a-dihydro-6H-benzo[c]chromen-6-one (21d) 
The title compound was obtained in 89% yield as colorless oil. [α]D25 = -67.9° (c = 
1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.38 (dd, J = 5.4 Hz, 3.6 Hz, 1H), 7.13 
(d, J = 8.4 Hz, 1H), 6.70 (dd, J = 8.7 Hz, 2.7 Hz, 1H), 6.61 (d, J = 2.7 Hz, 1H), 6.05 (dd, 
J = 3.3 Hz, 1.8 Hz, 1H), 3.97 (dd, J = 17.1 Hz, 6.0 Hz, 1H), 3.80 (s, 3H), 2.74 (dd, J = 
17.1 Hz, 8.7 Hz, 1H), 2.35 (dd, J = 19.2 Hz, 17.4 Hz, 1H), 2.02 (s, 3H); 13C NMR (75.5 
MHz, CDCl3) δ (ppm) 162.3, 160.0, 151.2, 146.3, 138.9, 126.7, 120.7, 118.2, 115.3, 
110.9, 102.2, 55.5, 34.8, 31.7, 23.8. The ee was determined to be 94% by HPLC on 
Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 70 / 30, 0.2 mL/min-1, λ = 254 nm, tr 
(major) = 44.44 min, tr (minor) = 126.73 min. 
 
(R)-3-Bromo-9-methyl-10,10a-dihydro-6H-benzo[c]chromen-6-one (21e) 
The title compound was obtained in 97% yield as white solid. M. P. 115-116 ºC; 
[α]D25 = -91.9° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.40 (dd, J = 5.7 Hz, 
3.6 Hz, 1H), 7.28-7.22 (m, 2H), 7.11 (dd, J = 8.1 Hz, 0.9 Hz, 1H), 6.07 (dd, J = 3.3 Hz, 
1.8 Hz, 1H), 3.98 (dd, J = 19.8 Hz, 6.3 Hz, 1H), 2.76 (dd, J = 17.1 Hz, 8.4 Hz, 1H), 2.38 
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(dd, J = 19.5 Hz, 17.7 Hz, 1H), 2.03 (s, 3H); 13C NMR (125 MHz, CDCl3) δ (ppm) 161.5, 
151.1, 146.4, 139.5, 127.5, 122.5, 121.1, 120.9, 120.4, 117.2, 34.4, 32.0, 23.8. The ee was 
determined to be 90% by HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 70 
/ 30, 0.4 mL/min-1, λ = 254 nm, tr (major) = 19.93 min, tr (minor) = 34.02 min. 
 
(R)-2-Bromo-9-methyl-10,10a-dihydro-6H-benzo[c]chromen-6-one (21f) 
The title compound was obtained in 94% yield as white solid. M. P. 123-124 ºC; 
[α]D25 = -103.2° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.42-7.34 (m, 3H), 
6.95 (d, J = 7.5 Hz, 1H), 6.07 (d, J = 5.1 Hz, 1H), 4.04 (dd, J = 19.8 Hz, 7.2 Hz, 1H), 
2.76 (dd, J = 17.1 Hz, 8.7 Hz, 1H), 2.41 (dd, J = 19.5 Hz, 17.7 Hz, 1H), 2.04 (s, 3H); 13C 
NMR (75.5 MHz, CDCl3) δ (ppm) 161.5, 149.7, 146.3, 139.4, 131.7, 129.1, 125.5, 120.8, 
119.0, 117.0, 117.0, 34.4, 32.2, 23.8. The ee was determined to be 93% by HPLC on 
Daicel Chiralpak IC (25 cm), Hexanes / IPA = 90 / 10, 0.5 mL/min-1, λ = 254 nm, tr 
(major) = 119.84 min, tr (minor) = 141.56 min. 
 
(R)-9-Methyl-2-nitro-10,10a-dihydro-6H-benzo[c]chromen-6-one (21g) 
The title compound was obtained in 92% yield as white solid. M. P. 250 ºC 
decomposed; [α]D25 = -46.9° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 8.19-
8.16 (m, 2H), 7.47 (dd, J = 5.7 Hz, 3.6 Hz, 1H), 7.20 (d, J = 9.0 Hz, 1H), 6.13 (dd, J = 
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3.6 Hz, 1.8 Hz, 1H), 4.12 (dd, J = 18.3 Hz, 7.2 Hz, 1H), 2.91 (dd, J = 17.1 Hz, 8.7 Hz, 
1H), 2.48 (dd, J = 19.5 Hz, 17.4 Hz, 1H), 2.09 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ 
(ppm) 155.2, 146.9, 144.2, 140.5, 124.7, 124.4, 122.5, 121.0, 118.3, 115.8, 34.3, 32.3, 
23.9. The ee was determined to be 91% by HPLC on Daicel Chiralpak IB (25 cm), 
Hexanes / IPA = 90 / 10, 0.3 mL/min-1, λ = 254 nm, tr (major) = 64.43 min, tr (minor) = 
72.11 min. 
 
(R)-3-methoxy-10,10a-dihydro-6H-benzo[c]chromen-6-one (21h) 
The title compound was obtained in 85% yield as yellow oil. [α]D25 = -15.8° (c = 1, 
CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.40 (s, 1H), 7.12 (d, J = 8.7 Hz, 1H), 6.71 
(d, J = 8.7 Hz, 1H), 6.40-6.28 (m, 2H), 3.96 (dd, J = 20.4 Hz, 8.4 Hz, 1H), 3.80 (s, 3H), 
2.99-2.88 (m, 1H), 2.31 (t, J = 19.2 Hz, 1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 
159.6, 137.5, 134.4, 126.9, 125.1, 115.0, 111.1, 102.3, 55.5, 31.1, 28.8. The ee was 
determined to be 92% by HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 70 
/ 30, 0.4 mL/min-1, λ = 254 nm, tr (major) = 23.33 min, tr (minor) = 39.18 min. 
O O
Ph  
(R)-9-Phenyl-10,10a-dihydro-6H-benzo[c]chromen-6-one (21i) 
The title compound was obtained in 91% yield as yellow solid. M. P. 133-134 ºC; 
[α]D25 = -309.4° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.60-7.56 (m, 3H), 
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7.46-7.25 (m, 5H), 7.18 (td, J = 7.5 Hz, 1.2 Hz, 1H), 7.10 (dd, J = 8.1 Hz, 0.9 Hz, 1H), 
6.67 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 4.18 (ddd, J = 20.0 Hz, 8.1 Hz, 3.0 Hz, 1H), 3.40 (dd, J 
= 16.5 Hz, 8.1 Hz, 1H), 2.87-2.74 (m, 1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 161.9, 
150.6, 144.9, 139.0, 138.6, 129.1, 128.8, 128.6, 126.2, 125.6, 124.6, 122.9, 121.0, 119.9, 
117.4, 32.5, 31.9. The ee was determined to be 94% by HPLC on Daicel Chiralpak IB 
(25 cm), Hexanes / IPA = 90 / 10, 0.3 mL/min-1, λ = 210 nm, tr (major) = 40.94 min, tr 
(minor) = 45.88 min. 
 
(R)-3-Bromo-9-phenyl-10,10a-dihydro-6H-benzo[c]chromen-6-one (21j) 
The title compound was obtained in 89% yield as yellow solid. M. P. 182-183 ºC; 
[α]D25 = -287.5° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.59-7.57 (m, 3H), 
7.46-7.38 (m, 3H), 7.32-7.21 (m, 3H), 6.67 (dd, J = 6.0 Hz, 2.7 Hz, 1H), 4.11 (ddd, J = 
20.0 Hz, 8.1 Hz, 3.3 Hz, 1H), 3.36 (dd, J = 16.5 Hz, 8.1 Hz, 1H), 2.85-2.72 (m, 1H); 13C 
NMR (75.5 MHz, CDCl3) δ (ppm) 161.2, 151.1, 145.1, 139.2, 138.8, 129.3, 128.8, 127.6, 
125.6, 122.1, 121.3, 121.0, 120.5, 119.0, 32.3, 31.8. The ee was determined to be 92% by 
HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 70 / 30, 0.4 mL/min-1, λ = 
254 nm, tr (major) = 25.62 min, tr (minor) = 36.88 min. 
O OBr
 
55 
 
(R)-3-Bromo-9-(m-tolyl)-10,10a-dihydro-6H-benzo[c]chromen-6-one (21k) 
The title compound was obtained in 93% yield as yellow oil. [α]D25 = -420.8° (c = 
1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.58 (dd, J = 6.0 Hz, 3.3 Hz, 1H), 7.38 
(d, J = 2.4 Hz, 1H), 7.34-7.19 (m, 5H), 6.66 (dd, J = 6.0 Hz, 2.7 Hz, 1H), 4.10 (ddd, J = 
20.0 Hz, 8.1 Hz, 3.0 Hz, 1H), 3.35 (dd, J = 16.8 Hz, 8.1 Hz, 1H), 2.83-2.70 (m, 1H), 2.41 
(s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 161.2, 151.1, 145.3, 139.3, 138.8, 138.5, 
130.1, 128.7, 127.6, 126.3, 122.8, 122.1, 121.3, 120.9, 120.5, 118.9, 32.4, 31.9, 21.5. The 
ee was determined to be 92% by HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes / 
IPA = 70 / 30, 0.4 mL/min-1, λ = 254 nm, tr (major) = 21.10 min, tr (minor) = 28.83 min. 
 
(R)-3-Bromo-9-(p-tolyl)-10,10a-dihydro-6H-benzo[c]chromen-6-one (21l) 
The title compound was obtained in 91% yield as yellow solid. M. P. 171-172 ºC; 
[α]D25 = -370.2° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.58 (dd, J = 6.0 
Hz, 3.3 Hz, 1H), 7.48 (d, J = 8.1 Hz, 2H), 7.32-7.21 (m, 5H), 6.65 (dd, J = 6.0 Hz, 2.7 
Hz, 1H), 4.10 (ddd, J = 19.8 Hz, 8.1 Hz, 3.3 Hz, 1H), 3.36 (dd, J = 16.8 Hz, 8.1 Hz, 1H), 
2.81-2.68 (m, 1H), 2.40 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 161.3, 151.2, 
145.1, 139.6, 139.4, 135.8, 129.5, 127.6, 125.6, 122.2, 121.3, 120.5, 120.2, 118.5, 32.3, 
31.7, 21.3. The ee was determined to be 90% by HPLC on Daicel Chiralpak AS-H (25 
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cm), Hexanes / IPA = 70 / 30, 0.4 mL/min-1, λ = 254 nm, tr (major) = 23.47 min, tr 
(minor) = 31.53 min. 
 
(R)-9-(4-Fluorophenyl)-3-methyl-10,10a-dihydro-6H-benzo[c]chromen-6-one (21m) 
The title compound was obtained in 87% yield as yellow solid. M. P. 162-163 ºC; 
[α]D25 = -304.7° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.59-7.54 (m, 1H), 
7.26-7.21 (m, 1H), 7.12 (t, J = 6.6 Hz, 2H), 6.99 (d, J = 7.8 Hz, 1H), 6.92 (s, 1H), 6.61 
(dd, J = 6.0 Hz, 2.7 Hz, 1H), 4.14 (ddd, J = 19.8 Hz, 7.8 Hz, 3.0 Hz, 1H), 3.33 (dd, J = 
16.5 Hz, 8.1 Hz, 1H), 2.82-2.69 (m, 1H), 2.36 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
(ppm) 162.1, 150.4, 143.7, 138.9, 138.3, 135.2, 127.5, 127.4, 125.9, 125.4, 120.9, 120.2, 
119.7, 117.8, 115.9, 115.7, 32.3, 32.1, 21.0. The ee was determined to be 92% by HPLC 
on Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 70 / 30, 0.4 mL/min-1, λ = 254 nm, 
tr (major) = 28.48 min, tr (minor) = 75.83 min. 
 
(R)-3-Bromo-9-(3-bromophenyl)-10,10a-dihydro-6H-benzo[c]chromen-6-one (21n) 
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The title compound was obtained in 83% yield as yellow oil. [α]D25 = -206.7° (c = 
1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.69 (t, J = 1.8 Hz, 1H), 7.57 (dd, J = 
6.0 Hz, 3.6 Hz, 1H), 7.50 (d, J = 8.1 Hz, 2H), 7.33-7.22 (m, 4H), 6.66 (dd, J = 5.7 Hz, 2.7 
Hz, 1H), 4.12 (ddd, J = 20.0 Hz, 8.4 Hz, 3.3 Hz, 1H), 3.30 (dd, J = 16.8 Hz, 8.4 Hz, 1H), 
2.83-2.70 (m, 1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 161.0, 151.0, 143.3, 141.0, 
138.6, 132.0, 130.3, 128.7, 127.7, 127.6, 124.2, 123.1, 122.0, 121.8, 121.5, 120.6, 119.9, 
32.3, 31.6. The ee was determined to be 92% by HPLC on Daicel Chiralpak AS-H (25 
cm), Hexanes / IPA = 70 / 30, 0.4 mL/min-1, λ = 254 nm, tr (major) = 29.37 min, tr 
(minor) = 39.79 min. 
 
(R)-3-Bromo-9-(3,4-dichlorophenyl)-10,10a-dihydro-6H-benzo[c]chromen-6-one 
(21o) 
The title compound was obtained in 88% yield as yellow solid. M. P. 202-203 ºC; 
[α]D25 = -284.7° (c = 1, CHCl3); 1H NMR (500 MHz, CDCl3) δ (ppm) 7.64 (d, J = 2.0 Hz, 
1H), 7.56 (dd, J = 5.5 Hz, 3.5 Hz, 1H), 7.50 (d, J = 8.5 Hz, 1H), 7.41 (dd, J = 8.5 Hz, 2.0 
Hz, 1H), 7.32 (dd, J = 8.5 Hz, 1.5 Hz, 1H), 7.27 (d, J = 2.0 Hz, 1H), 7.23 (d, J = 8.0 Hz, 
1H), 6.67 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 4.13 (ddd, J = 20.0 Hz, 8.0 Hz, 3.0 Hz, 1H), 2.81-
2.73 (m, 1H); 13C NMR (125 MHz, CDCl3) δ (ppm) 160.9, 151.0, 142.2, 138.8, 138.4, 
133.2, 133.1, 130.8, 127.8, 127.5, 124.8, 122.2, 121.6, 121.6, 120.6, 120.2, 32.3, 31.5. 
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The ee was determined to be 94% by HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes 
/ IPA = 70 / 30, 0.4 mL/min-1, λ = 254 nm, tr (major) = 30.05 min, tr (minor) = 40.02 min. 
 
(10R,10aR)-3-Bromo-10-methyl-10,10a-dihydro-6H-benzo[c]chromen-6-one (21p) 
The title compound was obtained in 81% yield as colorless oil. [α]D25 = -199.1° (c = 
1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.31-7.14 (m, 4H), 6.12-5.99 (m, 2H), 
3.71 (d, J = 13.2 Hz, 1H), 3.12-3.00 (m, 1H), 1.51 (d, J = 6.9 Hz, 1H); 13C NMR (125 
MHz, CDCl3) δ (ppm) 162.9, 151.5, 139.9, 135.7, 127.5, 125.8, 124.3, 121.1, 120.6, 38.5, 
33.3, 23.7. The ee was determined to be 90% by HPLC on Daicel Chiralpak AS-H (25 
cm), Hexanes / IPA = 90 / 10, 0.2 mL/min-1, λ = 254 nm, tr (minor) = 53.02 min, tr 
(major) = 72.42 min. 
 
(10R,10aR)-10-Methyl-2-nitro-10,10a-dihydro-6H-benzo[c]chromen-6-one (21q) 
The title compound was obtained in 91% yield as white solid. M. P. 114-115 ºC; 
[α]D25 = -288.2° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 8.26-8.18 (m, 2H), 
7.28-7.21 (m, 2H), 6.17-6.07 (m, 2H), 3.85 (d, J = 14.7 Hz, 1H), 3.22-3.14 (m, 1H), 1.60 
(d, J = 6.9 Hz, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 155.6, 144.4, 140.2, 136.8, 
126.6, 124.3, 121.1, 120.8, 119.2, 118.4, 38.7, 33.3, 23.7. The ee was determined to be 
90% by HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes/IPA = 70/30, 0.4 mL/min-1, 
λ = 254 nm, tr (minor) = 29.15 min, tr (major) = 44.51 min. 
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 (10R,10aR)-10-Ethyl-2-nitro-10,10a-dihydro-6H-benzo[c]chromen-6-one (21r) 
The title compound was obtained in 89% yield as light yellow oil. [α]D25 = -409.7° 
(c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 8.21-8.15 (m, 2H), 7.27-7.19 (m, 
2H), 6.22-6.13 (m, 2H), 3.92 (dd, J = 13.2 Hz, 1.8 Hz, 1H), 3.14-3.06 (m, 1H), 2.04-1.76 
(m, 2H), 1.19 (t, J = 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ (ppm) 162.2, 155.6, 
144.4, 137.7, 136.2, 127.4, 124.2, 121.4, 120.5, 119.3, 118.3, 38.9, 36.0, 29.9, 10.7. The 
ee was determined to be 90% by HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes/IPA 
= 70/30, 0.4 mL/min-1, λ = 254 nm, tr (minor) = 26.37 min, tr (major) = 38.99 min. 
 
(10R,10aR)-2-Nitro-10-propyl-10,10a-dihydro-6H-benzo[c]chromen-6-one (21s) 
The title compound was obtained in 90% yield as light yellow solid. M. P. 86-87 
ºC; [α]D25 = -464.7° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 8.21-8.18 (m, 
2H), 7.27-7.19 (m, 2H), 6.22-6.11 (m, 2H), 3.91 (dd, J = 13.8 Hz, 1.8 Hz, 1H), 3.17-3.11 
(m, 1H), 1.90-1.74 (m, 2H), 1.71-1.55 (m, 2H), 1.09 (t, J = 7.2 Hz, 3H); 13C NMR (75.5 
MHz, CDCl3) δ (ppm) 162.2, 155.6, 144.4, 138.0, 136.2, 127.4, 124.2, 121.1, 120.5, 
119.4, 118.3, 39.4, 37.4, 36.4, 19.6, 14.2. The ee was determined to be 94% by HPLC on 
Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 90 / 10, 0.2 mL/min-1, λ = 254 nm, tr 
(minor) = 83.68 min, tr (major) = 107.78 min. 
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 Chapter 3 
Construction of Chiral Bridged Tricyclic Benzopyrans 
 
3.1 Background 
The discovery of powerful simplifying transformations for rapid access to the core 
structures featured in natural products is a central goal of organic synthesis. The bridged 
tricyclic benzopyran framework A is present in a fascinating array of structurally diverse, 
biologically intriguing complex natural products, such as cannabinoid,1 
oxabicyclononane, murrayamines D and cyclomahanimbine,2 and kuwanol B (Figure 1),3 
sanggenone R,4a mulberrofurans I and S and sorocenol B,4b and saustralisin B,4c 
mongolicin C,4d and isorubraine, etc.4e  
Figure 3.1 Bridged tricyclic benzopyran core unit A in natural products 
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The construction of the bridged scaffold requires installing two contiguous chiral 
centers including one quaternary center. Typically, this substructure is built through acid 
catalyzed cyclizations of phenolic alkene precursors.5 However, asymmetric synthesis of 
the scaffolds remains elusive. To the best of our knowledge, only a single study was 
reported by Yao and coworkers using a binary Pd(OAc)2 and (S)-Trip system catalyzed 
an enantioselective cascade annulation process between 2-hydroxystyrenes and 2-
alkynylbenaldehyes or 1-(2-alkynylphenyl)ketones.6 To streamline substantial advances 
in this arena, new catalytic asymmetric methodologies using simple substances are more 
appealing. 
3.2 Research Design 
An efficient 2-step access to the chiral complex molecular architecture A was 
investigated (Scheme 3.1). Enantioselective decarboxylative Diels–Alder reaction and a 
'one-pot' reduction-acid catalyzed stereoselective cyclization proceeded smoothly to 
furnish the desired structure.  
Scheme 3.1 Two-step synthesis of bridged tricyclic benzopyran 
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13:1-21:1 dr
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As a useful application of the asymmetric decarboxylative Diels–Alder reaction 
adducts, a reduction-acid catalyzed stereoselective cyclization sequence for the access to 
bridged tricyclic benzopyran is discovered unexpectedly. A new 'one-pot' protocol of 
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LiAlH4 or NaBH4 mediated reduction of Diels–Alder product and subsequent acid 
(workup) catalyzed intramolecular highly stereoselective cyclization of the Diels–Alder 
adducts was identified for the efficient formation of the chiral bridged tricyclic 
benzopyran framework 4. The cyclization involves an interesting phenolic attack of the 
diene moiety driven by dehydration of the allylic alcohol in 3 (Scheme 3.2). 
Scheme 3.2 Sequence of transforming 1 to bridged tricyclic benzopyran 4 
 
3.3 Scope Expansion 
With Diels–Alder products 1 in hand, we performed the investigation for their 
transformation to the bridged tricyclic benzopyrans 4 (Scheme 3.1). As mentioned above, 
acid triggered cyclization of phenols with alkenes has been studied in the synthesis of the 
scaffold.5 Inspired by the studies, we conceived a possibility of new cyclization between 
a phenol and a diene in the presence of an acid (Scheme 3.2). The required precursor diol 
2 could be obtained via the reduction of the corresponding lactone 1 (Table 3.1, entry 1). 
Surprisingly, after the reduction by LiAlH4, the chiral bridged tricyclic benzopyran 4a 
was obtained directly after workup with 10% HCl aqueous solution without requiring an 
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additional acid treatment. Moreover, the unexpected 'one-pot' procedure proceeded 
smoothly in 86% yield and with excellent diastereoselectivity (> 20:1 dr). 
Table 3.1 Formation of 4 by 'one-pot' reduction-acid catalyzed cyclization of 1.[a] 
O R
1
R4
R5
R2
O
R4
R3
R2
R1
O
H
1 4
Method A:
LiAlH4, THF, 1 h, 0 oC then
quenched by 10% HCl (aq.)
Method B:
NaBH4, MeOH, 15 h, rt then
quenched by 10% HCl (aq.)
1
3
5
7
 
Entry R1, R2, R3, R4, R5 1 4 Method Yield (%)[b] 
dr  
(%)[c] 
1 Me, H, H, H, H, H 1a 4a A 86 >20:1 
2 Me, H, Me, H, Me 1b 4b A 91 >20:1 
3 Me, H, H, Me, H 1c 4c A 93 >20:1 
4 Me, H, MeO, H, MeO 1d 4d A 87 >20:1[d]
5 Me, H, H, Br, H 1f 4e A 85 5.5:1 
6 H, H, MeO, H, MeO 1h 4f A 84 >20:1 
7 Ph, H, Br, H, H 1j 4g A 89 >20:1 
8 3-MePh, H, Br, H, H 1k 4h A 87 >20:1 
9 H, Me, Br, H, H 1p 4i A 83 12:1 
10 H, Me, Br, H, Br 1p 4j B 75 >20:1 
[a] Conditions: unless specified, see Experimental Section. [b] Isolated yields. [c] 
Determined by 1H NMR. [d] Determined by chiral HPLC using a chiral stationary phase 
with 91% ee. 
We also extended the protocol to other substrates (entries 2-9). In general, high 
yields (83-93%) and good to excellent dr (5.5:1 - >20:1) were achieved with these 
representative structurally diverse molecules 1. Furthermore, the enantioselectivity was 
largely maintained in the two step transformations, as demonstrated in the case of 4d with 
91% ee (Table 3.1, entry 4). It is noteworthy that unexpectedly, the debromination 
concurred with substrates bearing the bromo atom at position 7 (e.g., R3, entries 7-9), 
67 
 
while Br at 6-position is not affected (entry 5). The use of milder NaBH4 could overcome 
this problem (entry 10). 
The absolute configuration was confirmed by X-ray crystallographic analysis of 
single crystal 4e (Figure 3.2). 
Figure 3.2 X-Ray Structure of 4e 
 
Conclusion 
The Diels–Alder adducts are smoothly transformed into the targets by a novel but 
unexpected 'one-pot' protocol of LiAlH4 or NaBH4 mediated reduction and subsequent 
acid (workup) catalyzed highly stereoselective cyclization.  We anticipate that the two 
new synthetic strategies hold great potential in the exploration of novel organic 
transformations.  The application of the chiral bridged tricyclic benzopyran core in the 
synthesis of natural products and biologically relevant molecules is also under 
investigation. 
Experimental Section 
General Procedure for the Preparation of 4a-j 
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Method A: A solution of Diels–Alder product 1a (0.064 g, 0.30 mmol) in 0.5 mL of THF 
was injected to the mixture of LiAlH4 (0.023 g, 0.60 mmol) in 5 mL of THF at 0 ºC. The 
mixture was stirred for 1 h at 0 ºC and quenched with 20 mL of 10% HCl solution. The 
reduced product was consumed completely monitored by TLC after stirring for 1 h. The 
product was extracted with 10 mL of ethyl acetate three times. The combined organic 
layer was dried with sodium sulfate and evaporated. The crude product was purified by 
column chromatography with hexane and ethyl acetate to give 0.0516 g of product. 
 
Method B: To a solution of Diels–Alder product 1p (0.082 g, 0.28 mmol) in 2 mL 
MeOH was added NaBH4 (0.053 g, 1.40 mmol) at room temperature. The mixture was 
stirred for 15 h and quenched with 20 mL 10% HCl solution. The reduced product was 
consumed completely monitored by TLC after stirring for 1 h. The product was extracted 
with 10 mL ethyl acetate three times. The combined organic layer was dried with sodium 
sulfate and evaporated. The crude product was purified by column chromatography with 
hexane and ethyl acetate to give 0.058 g of product. 
Physical and Spectroscopic Data for 4a-j 
 
(2R,6S)-2-Methyl-5-methylene-5,6-dihydro-2H-2,6-methanobenzo[b]oxocine (4a) 
The title compound was obtained in 86% yield for two steps by method A as 
colorless oil. [α]D25 = +398.0° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.13-
7.08 (m, 2H), 6.86-6.77 (m, 2H), 6.21 (d, J = 9.6 Hz, 1H), 5.64 (d, J = 9.6 Hz, 1H), 5.14 
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(s, 1H), 4.86 (s, 1H), 3.61 (t, J = 2.7 Hz, 1H), 1.96 (d, J = 2.1 Hz, 1H), 1.56 (s, 3H); 13C 
NMR (75.5 MHz, CDCl3) δ (ppm) 153.1, 147.3, 131.6, 130.7, 128.9, 128.1, 125.0, 120.1, 
117.1, 111.4, 70.7, 39.4, 34.2, 27.3; DEPT-135 (75.5 MHz, CDCl3) δ (ppm) 131.6, 130.7, 
128.9, 128.1, 120.1, 117.1, 111.4, 39.4, 34.2, 27.3. 
  
(2R,6S)-2,9-Dimethyl-5-methylene-5,6-dihydro-2H-2,6-methanobenzo[b]oxocine 
(4b) 
The title compound was obtained in 91% yield for two steps by method A as white 
solid. M. P. 77-78 ºC; [α]D25 = +416.7° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) 6.96 
(d, J = 7.5 Hz, 1H), 6.65 (d, J = 7.8 Hz, 1H), 6.62 (s, 1H), 6.19 (d, J = 9.6 Hz, 1H), 5.63 
(d, J = 9.6 Hz, 1H), 5.11 (s, 1H), 4.84 (s, 1H), 3.56 (s, 1H), 2.24 (s, 3H), 1.93 (d, J = 2.4 
Hz, 2H), 1.54 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 152.8, 147.4, 138.0, 131.6, 
130.7, 128.6, 122.1, 121.2, 117.4, 111.2, 70.6, 39.0, 34.4, 27.3, 21.1; DEPT-135 (75.5 
MHz, CDCl3) δ (ppm) 131.6, 130.7, 128.6, 121.2, 117.4, 111.2, 39.0, 34.4, 27.3, 21.1. 
 
(2R,6S)-2,8-Dimethyl-5-methylene-5,6-dihydro-2H-2,6-methanobenzo[b]oxocine (4c) 
The title compound was obtained in 93% yield for two steps by method A as 
colorless oil. [α]D25 = +375.8° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) 6.93-6.89 (m, 
2H), 6.69 (d, J = 8.1 Hz, 1H), 6.20 (d, J = 9.6 Hz, 1H), 5.63 (d, J = 9.6 Hz, 1H), 5.14 (s, 
70 
 
1H), 4.86 (s, 1H), 3.55 (t, J = 2.7 Hz, 1H), 2.24 (s, 3H), 1.93 (d, J = 2.4 Hz, 2H), 1.55 (s, 
3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 150.9, 147.4, 131.6, 130.6, 129.2, 128.9, 
124.6, 116.8, 111.3, 70.5, 39.4, 34.4, 27.4, 20.5; DEPT-135 (75.5 MHz, CDCl3) δ (ppm) 
131.6, 130.6, 129.2, 128.9, 116.8, 111.3, 39.4, 34.4, 27.4, 20.5. 
 
(2R,6S)-9-Methoxy-2-methyl-5-methylene-5,6-dihydro-2H-2,6-
methanobenzo[b]oxocine (4d) 
The title compound was obtained in 87% yield for two steps by method A as 
colorless oil. [α]D25 = +432.9° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) 6.97 (d, J = 
8.4 Hz, 1H), 6.44 (dd, J = 8.1 Hz, 2.4 Hz, 1H), 6.35 (d, J = 2.4 Hz, 1H), 6.20 (d, J = 9.6 
Hz, 1H), 5.64 (d, J = 9.6 Hz, 1H), 5.11 (s, 1H), 4.84 (s, 1H), 3.72 (s, 3H), 3.54 (t, J = 2.7 
Hz, 1H), 1.93 (d, J = 2.7 Hz, 1H), 1.55 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 
159.7, 153.8, 147.4, 131.4, 130.8, 129.3, 117.4, 111.1, 107.5, 101.4, 70.8, 55.2, 38.7, 
34.5, 27.3; DEPT-135 (75.5 MHz, CDCl3) δ (ppm) 131.4, 130.8, 129.3, 111.1, 107.5, 
101.4, 55.2, 38.7, 34.5, 27.3.  The ee was determined to be 91% by HPLC on Daicel 
Chiralpak IC (25 cm), Hexanes/IPA= 90/10, 0.5 mL/min-1, λ = 254 nm, tr (major) = 9.86 
min, tr (minor) = 11.43 min. 
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(2R,6S)-8-Bromo-2-methyl-5-methylene-5,6-dihydro-2H-2,6-
methanobenzo[b]oxocine (4e) 
The title compound was obtained in 85% yield for two steps by method A as white 
solid. [α]D25 = +297.4° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) 7.20-7.16 (m, 2H), 
6.66 (d, J = 8.7 Hz, 1H), 6.21 (d, J = 9.6 Hz, 1H), 5.63 (d, J = 9.6 Hz, 1H), 5.15 (s, 1H), 
4.90 (s, 1H), 3.56 (t, J = 2.7 Hz, 1H), 1.93 (d, J = 2.7 Hz, 1H), 1.55 (s, 3H); 13C NMR 
(75.5 MHz, CDCl3) δ (ppm) 152.4, 146.6, 131.5, 131.4, 130.9, 130.7, 127.2, 119.0, 
112.1, 112.0, 71.0, 39.3, 33.9, 27.2; DEPT-135 (75.5 MHz, CDCl3) δ (ppm) 131.5, 131.4, 
130.9, 130.7, 119.0, 112.1, 39.3, 33.9, 27.2. 
 
(2R,6S)-9-Methoxy-5-methylene-5,6-dihydro-2H-2,6-methanobenzo[b]oxocine (4f) 
The title compound was obtained in 84% yield for two steps by method A as 
colorless oil. [α]D25 = +229.4° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) 6.96 (d, J = 
8.4 Hz, 1H), 6.44 (dd, J = 8.4 Hz, 2.4 Hz, 1H), 6.37 (d, J = 2.4 Hz, 1H), 6.30 (d, J = 9.6 
Hz, 1H), 5.93 (dd, J = 9.6 Hz, 6.0 Hz, 1H), 5.14 (s, 1H), 4.86 (s, 1H), 4.85-4.82 (m, 1H), 
3.73 (s, 3H), 3.53 (s, 1H), 2.13 (dt, J = 12.9 Hz, 2.7 Hz, 1H), 1.98 (dt, J = 12.6 Hz, 2.7 
Hz, 1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 159.8, 152.8, 147.6, 132.4, 129.6, 126.1, 
117.9, 111.8, 107.4, 101.8, 66.4, 55.2, 37.2, 27.9; DEPT-135 (75.5 MHz, CDCl3) δ (ppm) 
132.4, 129.6, 126.1, 111.8, 107.4, 101.8, 66.4, 55.2, 37.2, 27.9. 
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 (2R,6S)-5-Methylene-2-phenyl-5,6-dihydro-2H-2,6-methanobenzo[b]oxocine (4g) 
The title compound was obtained in 89% yield for two steps by method A as 
colorless oil. [α]D25 = +141.3° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) 7.61-7.57 (m, 
2H), 7.44-7.38 (m, 2H), 7.32 (tt, J = 7.2 Hz, 1.2 Hz, 1H), 7.20-7.12 (m, 2H), 6.96 (dd, J = 
8.1 Hz, 0.9 Hz, 1H), 6.91-6.86 (m, 1H), 6.41 (d, J = 9.6 Hz, 1H), 5.86 (d, J = 9.6 Hz, 
1H), 5.22 (s, 1H), 4.95 (s, 1H), 3.68 (t, J = 2.7 Hz, 1H), 2.22 (dd, J = 12.9 Hz, 2.4 Hz, 
1H), 2.12 (ddd, J = 12.9 Hz, 3.6 Hz, 1.8 Hz, 1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 
152.9, 146.9, 144.9, 131.7, 130.7, 129.0, 128.4, 128.3, 127.5, 125.0, 120.5, 117.5, 111.9, 
74.3, 39.6, 36.5; DEPT-135 (75.5 MHz, CDCl3) δ (ppm) 131.7, 130.7, 129.0, 128.4, 
128.3, 127.5, 125.0, 120.5, 117.5, 111.9, 39.6, 36.5. 
 
(2R,6S)-5-Methylene-2-(m-tolyl)-5,6-dihydro-2H-2,6-methanobenzo[b]oxocine (4h) 
The title compound was obtained in 87% yield for two steps by method A as 
colorless oil. [α]D25 = +123.8° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) 7.41-7.38 (m, 
2H), 7.30 (t, J = 7.5 Hz, 1H), 7.20-7.13 (m, 3H), 6.97 (d, J = 7.5 Hz, 1H), 6.92-6.87 (m, 
1H), 6.41 (d, J = 9.6 Hz, 1H), 5.86 (d, J = 9.6 Hz, 1H), 5.23 (s, 1H), 4.95 (s, 1H), 3.68 (t, 
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J = 2.7 Hz, 1H), 2.40 (s, 3H), 2.22 (dd, J = 12.9 Hz, 2.4 Hz, 1H), 2.12 (ddd, J = 12.9 Hz, 
3.3 Hz, 1.5 Hz, 1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 153.0, 147.0, 144.9, 138.0, 
131.6, 130.9, 128.9, 128.2, 125.7, 125.1, 122.1, 120.4, 117.5, 111.8, 74.3, 39.7, 36.5, 
21.6; DEPT-135 (75.5 MHz, CDCl3) δ (ppm) 131.6, 130.9, 128.9, 128.2, 125.7, 122.1, 
120.4, 117.5, 111.8, 39.7, 36.5, 21.6. 
 
(2S,6S,11S)-11-Methyl-5-methylene-5,6-dihydro-2H-2,6-methanobenzo[b]oxocine 
(4i) 
The title compound was obtained in 83% yield for two steps by method A as 
colorless oil. [α]D25 = +287.1° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) 6.96 (td, J = 
7.5 Hz, 1.5 Hz, 1H), 7.04 (dd, J = 7.2 Hz, 1.2 Hz, 1H), 6.86-6.79 (m, 2H), 6.29 (d, J = 9.6 
Hz, 1H), 5.75 (dd, J = 9.6 Hz, 5.7 Hz, 1H), 5.18 (s, 1H), 4.96 (s, 1H), 4.49 (td, J = 4.1 
Hz, 2.1 Hz, 1H), 3.32 (s, 1H), 2.34-2.27 (m, 1H), 0.98 (d, J = 6.9 Hz, 1H); 13C NMR 
(75.5 MHz, CDCl3) δ (ppm) 151.8, 144.9, 132.2, 129.1, 128.2, 126.6, 123.1, 120.2, 
117.2, 114.2, 71.4, 44.5, 30.6, 14.8; DEPT-135 (75.5 MHz, CDCl3) δ (ppm) 132.2, 129.1, 
128.3, 123.1, 120.2, 117.2, 114.2, 71.4, 44.5, 30.6, 14.8. 
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(2S,6S,11S)-9-Bromo-11-methyl-5-methylene-5,6-dihydro-2H-2,6-methanobenzo[b] 
oxocine (4j) 
75 
 
The title compound was obtained in 75% yield for two steps by method B as white 
solid. M. P. 80-81 ºC; [α]D25 = +292.7° (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) 
6.97-6.88 (m, 3H), 6.29 (d, J = 9.6 Hz, 1H), 5.74 (dd, J = 9.6 Hz, 5.7 Hz, 1H), 5.17 (s, 
1H), 4.97 (d, J = 0.3 Hz, 1H), 4.51-4.47 (m, 1H), 3.28 (s, 1H), 2.28-2.22 (m, 1H), 0.97 (d, 
J = 7.2 Hz, 1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 152.8, 144.4, 132.3, 130.2, 125.7, 
123.2, 123.0, 120.8, 120.2, 114.7, 71.5, 44.1, 30.4, 14.6; DEPT-135 (75.5 MHz, CDCl3) δ 
(ppm) 132.3, 130.2, 123.2, 123.0, 120.2, 114.7, 71.5, 44.1, 30.4, 14.6. 
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 Chapter 4 
Organocatalytic Casacde Synthesis of Xanthones 
4.1 Background 
Xanthones, as secondary metabolites of fungi, lichens, and bacteria, have been 
regarded as privileged structures because of their broad spectrum of biological activities.1 
The xanthone skeletons are widespread in a diverse range of biologically interesting and 
medicinal compounds such as arthothelin,2 chaetoxanthone A and B,3 conioxanthone A,4 
isoemericellin,5 and globosuxanthone C and D (Figure 4.1).6  
Figure 4.1 Natural products with xanthone core 
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Due to the prevalence and significance of the xanthone scaffolds, considerable 
efforts have been devoted to the organic synthesis of the structures since 100 years ago.1 
Different from the previously reported methods utilizing Friedel–Crafts reactions, 
rearrangements or photo-reactions for ring formation, more efficient processes including 
Michael-aldol sequences,7 coupling with arynes,8 xoidation reactions,9 coupling 
reactions10 for the synthesis of xanthone scaffolds have also been developed recently.  
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It is noteworthy that C-H activation-intramolecular coupling processes were 
explored with imine 1 to furnish xanthones 2 with up to 80% yield (Scheme 4.1).11 The 
2-iodophenyl group on imine was proposed to be crucial for efficient transformation. 
Oxidative addition of C-I site to Pd followed by palladium migration would produce the 
key intermediate for the formation of xanthones 2. 
Scheme 4.1 Synthesis of xanthones 2 via C-H activation from imine 
 
Li and co-workers reported that synthesis of xanthones could also be relealized 
through C-H activation-intramolecular coupling of aldehyde 3 with low to good yields 
(Scheme 4.2).12 It was disclosed that the process could be accomplished with inexpensive 
iron catalyst.13 
Scheme 4.2 Synthesis of xanthones 4 via C-H activation from aldehyde 
 
An ingenious process designed by Lei and co-workers was achieved for the 
synthesis of xanthones from simple diaryl ethers in 2012 (Scheme 4.3).14 Double C-H 
activation/carbonylation sequence was proposed for the efficient transformation from 
ether 5 to xanthones 4 in the presence of CO.  
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Scheme 4.3 Oxidative double C-H carbonylation of diaryl ethers 
 
Inverse-electron-demanding Diels–Alder reactions between diene 6 and dienophiles 
7 or 9 were conducted to provide xanthones 8 or 10 with low to 98% yield (Scheme 
4.4).15 
Scheme 4.4 Synthesis of xanthones via Diels–Alder reactions 
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It is obvious that low to moderate yields are generally obtained for most of the 
cases in the synthesis of xanthones through previously reported methods. Besides, the 
scope of these methods, especially the Diels–Alder reaction,15 is rather limited. The 
difficulty in preparing the substrates can also prevent the application of the process. 
4.2 Research Design 
Toward this end, we have designed a 'one-pot' strategy for the efficient synthesis of 
xanthones from readily available chromone-3-carboxylic acids and α,β-unsaturated 
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aldehydes (Scheme 4.5). Secondary amine catalyzed Diels–Alder reactions between enal 
11 and 12 followed by oxidation with DDQ would furnish the desired xanthone 14. The 
process can be performed in a 'one-pot' fashion since the same solvent can be utilized in 
the successive steps 
Scheme 4.5 Design of 'one-pot' synthesis of xanthones 
 
4.3 Optimization of Reaction Conditions 
The readily available 3-methyl-2-butenal 11a and chromone-3-carboxylic acid 12a 
are utilized as the model substrates for the two-step synthesis of xanthone 14a through a 
Diels–Alder-oxidation sequence (Table 4.1). 
It is found that decarboxylative Diels–Alder reaction between 3-methyl-2-butenal 
11a and chromone-3-carboxylic acid 12a in DCM proceeds smoothly to give the Diels–
Alder product 13a in 2h. However, transformation of 13a to xanthone 14a by directly 
adding PCC to the above mixture is sluggish to give 11% yield in 1h (Table 4.1, entry 1). 
The same process employing MnO2 as oxidant yields similar result (Table 4.1, entry 2). 
To our delight, the yield of 14a is improved significantly to 89% by the replacement of 
the oxidants with DDQ (Table 4.1, entry 3). More bulky secondary amine catalysts are 
proposed to be effective in improving reaction yields by the inhibition of side reactions. 
However, no benefit is gained regarding the yield of 14a by switching pyrrolidine to 
catalysts 15a or 15b (Table 4.1, entry 4-5). Screening solvents reveals that chloroform is 
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more beneficial to the process to furnish the desired product in 93% yield (Table 4.1, 
entry 6-7).  
Table 4.1 Optimization of reaction conditions[a] 
O
O
COOH
+
CHO 1) cat., solvent2) oxidant
rt
O
O
11a 12a 14a
N
H
Ph
OR
Ph
15aR = H
15bR = TMS
cat.
N
H
Pyrrolidine
 
entry cat. oxidant solvent yield (%)[b] 
1 Pyrrolidine PCC DCM 11 
2 Pyrrolidine MnO2 DCM 9 
3 Pyrrolidine DDQ DCM 89 
4 15a DDQ DCM 62 
5 15b DDQ DCM 85 
6 Pyrrolidine DDQ CHCl3 93 
7 Pyrrolidine DDQ toluene 87 
[a] Conditions: a mixture of 0.12 mmol 12a, 0.10 mmol 11a and 0.02 mmol catalyst in 
0.50 mL solvent is stirred for 2h. Then the reaction is stirred for additional 1h after the 
addition of 0.20 mmol oxidant. [b] Isolated yields. 
4.4 Expansion of Substrate Scope  
With the optimized reaction conditions in hand, the scope for the 'one-pot' synthesis 
of xanthones 14 is explored (Table 4.2). Various chromone-3-carboxylic acids are 
applied in the process with 3-methyl-2-butenal to give several kinds of substituted 
xanthones in 85-93% yields (Table 4.2, entry 1-4). The yields of the desired xathones 
decrease slightly when chromone-3-carboxylic acids 12 bearing electron-withdrawing 
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group at R3 position are utilized (Table 4.2, entry 3-4). Variation of the enal part is then 
investigated for the transformation. The yields of xathones 14e-14g further drop to 75-
81% when γ-substituted enals are employed (Table 4.2, entry 5-7). In accordance with the 
previous result (Table 4.2, entry 2), the methyl group on chromone-3-carboxylic acid is 
beneficial to the yields of the corresponding xanthones (Table 4.2, entry 8-10). 
Table 4.2 Scope of 'one-pot' synthesis of xanthones[a] 
O
O
COOH
+
CHO
R1
1. Pyrrolidine
CHCl3
2. DDQ
rt
O
O
R1
11 12 14
R3 R
3
R2
R2
 
Entry R1 R2 R3 14 Yield (%)[b] 
1 Me H H 14a 93 
2 Me H Me 14b 90 
3 Me H F 14c 85 
4 Me H Br 14d 89 
5 H Me H 14e 81 
6 H Et H 14f 75 
7 H n-Pr H 14g 77 
8 H Me Me 14h 89 
9 H Et Me 14i 85 
10 H n-Pr Me 14j 83 
[a] Conditions: a mixture of 0.12 mmol 12, 0.10 mmol 11 and 0.02 mmol pyrrolidine in 
0.50 mL CHCl3 is stirred for 2h. Then the reaction is stirred for additional 1h after the 
addition of 0.20 mmol DDQ. [b] Isolated yields. 
Conclusion 
Efficient 'one-pot' synthesis of aromatized xanthones has been accomplished by 
pyrrolidine catalyzed Diels–Alder reactions of readily available enals 11 and subsequent 
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oxidation reactions using DDQ. Application of the process in the synthesis of 
biologically significant molecules is under investigation. 
Experimental Section 
General Procedure for 'one-pot' synthesis of xanthones 
To a mixture of 0.12 mmol 12 and 0.02 mmol pyrrolidine in 0.50 mL CHCl3 is 
added 0.10 mmol 11. The reaction is allowed to be stirred for 2h under room temperature. 
Then the solution is stirred for another 1h after the addition of 0.20 mmol DDQ. The 
mixture was applied to column chromatography directly and eluted with hexane and ethyl 
acetate to give pure product 14. The purified compound is used for characterization. 
Physical and Spectroscopic Data for Oxathones 14a-14j 
 
3-Methyl-9H-xanthen-9-one (14a) 
1H NMR (300 MHz, CDCl3) δ (ppm) 8.33 (dd, J = 8.1 Hz, 1.8 Hz, 1H), 8.11 (d, J = 
8.1 Hz, 1H), 7.73-7.67 (m, 1H), 7.46 (d, J = 8.1 Hz, 1H), 7.36 (t, J = 7.5 Hz, 1H), 7.27 (s, 
1H), 7.18 (d, J = 8.1 Hz, 1H), 2.50 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 177.0, 
156.3, 156.1, 146.3, 134.5, 126.7, 126.5, 125.4, 123.7, 121.9, 119.6, 117.9, 117.7, 22.0. 
 
2,6-Dimethyl-9H-xanthen-9-one (14b) 
1H NMR (300 MHz, CDCl3) δ (ppm) 8.21 (d, J = 8.1 Hz, 1H), 8.10 (d, J = 1.2 Hz, 
1H), 7.50 (dd, J = 8.7 Hz, 2.1 Hz, 1H), 7.36 (d, J = 8.4 Hz, 1H), 7.25 (s, 1H), 7.17 (dd, J 
83 
 
= 8.1 Hz, 0.9 Hz, 1H), 2.49 (s, 3H), 2.46 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 
177.1, 156.3, 154.3, 146.1, 135.8, 133.5, 126.5, 126.0, 125.2, 121.5, 119.6, 117.6, 21.9, 
20.8. 
 
2-Fluoro-6-methyl-9H-xanthen-9-one (14c) 
1H NMR (300 MHz, CDCl3) δ (ppm) 8.19 (d, J = 8.1 Hz, 1H), 7.95 (dd, J = 8.1 Hz, 
2.7 Hz, 1H), 7.46-7.41 (m, 2H), 7.26 (s, 1H), 7.19 (d, J = 8.4 Hz, 1H), 2.51 (s, 3H); 13C 
NMR (75.5 MHz, CDCl3) δ (ppm) 176.2, 160.3, 156.2, 152.3, 146.7, 126.4, 125.7, 122.8, 
122.4, 119.9, 119.8, 118.8, 117.7, 111.5, 111.2, 22.0. 
 
2-Bromo-6-methyl-9H-xanthen-9-one (14d) 
1H NMR (300 MHz, CDCl3) δ (ppm) 8.41 (d, J = 2.4 Hz, 1H), 8.17 (d, J = 8.4 Hz, 
1H), 7.75 (dd, J = 8.7 Hz, 2.4 Hz, 1H), 7.35 (d, J = 8.7 Hz, 1H), 7.25 (s, 1H), 7.19 (dd, J 
= 8.1 Hz, 0.6 Hz, 1H), 2.50 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 175.7, 156.1, 
154.8, 146.8, 137.3, 129.1, 126.5, 125.8, 123.1, 119.9, 119.2, 117.7, 116.9, 22.0. 
 
4-Methyl-9H-xanthen-9-one (14e) 
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1H NMR (300 MHz, CDCl3) δ (ppm) 8.34 (dd, J = 8.1 Hz, 1.8 Hz, 1H), 8.19 (dd, J 
= 7.8 Hz, 1.2 Hz, 1H), 7.75-7.69 (m, 1H), 7.54 (t, J = 8.4 Hz, 2H), 7.40-7.35 (m, 1H), 
7.26 (t, J = 7.8 Hz, 1H), 2.56 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 177.5, 
156.1, 154.5, 135.7, 134.6, 127.2, 126.7, 124.3, 123.8, 121.6, 118.0, 15.8. 
O
O
 
4-Ethyl-9H-xanthen-9-one (14f) 
1H NMR (300 MHz, CDCl3) δ (ppm) 8.34 (dd, J = 7.8 Hz, 1.5 Hz, 1H), 8.20 (dd, J 
= 8.1 Hz, 1.5 Hz, 1H), 7.76-7.70 (m, 1H), 7.59 (dt, J = 7.2 Hz, 0.9 Hz, 1H), 7.53 (dd, J = 
8.4 Hz, 0.3 Hz, 1H), 7.41-7.26 (m, 2H), 3.00 (q, J = 7.8 Hz, 2H), 1.37 (t, J = 7.5 Hz, 3H); 
13C NMR (75.5 MHz, CDCl3) δ (ppm) 177.6, 156.0, 154.2, 134.6, 134.1, 133.1, 126.7, 
124.3, 123.8, 123.6, 121.8, 121.6, 118.0, 22.9, 14.1. 
 
4-Propyl-9H-xanthen-9-one (14g) 
1H NMR (300 MHz, CDCl3) δ (ppm) 8.34 (dd, J = 8.1 Hz, 1.8 Hz, 1H), 8.21 (dd, J 
= 8.1 Hz, 1.8 Hz, 1H), 7.76-7.70 (m, 1H), 7.58-7.51 (m, 2H), 7.40-7.26 (m, 2H), 2.94 (t, J 
= 7.5 Hz, 2H), 1.85-1.72 (m, 2H), 1.03 (t, J = 7.2 Hz, 3H); 13C NMR (75.5 MHz, CDCl3) 
δ (ppm) 177.6, 156.0, 154.3, 135.0, 134.6, 131.6, 126.7, 124.4, 123.8, 123.4, 121.8, 
121.6, 118.0, 31.8, 23.0, 14.0. 
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 2,5-Dimethyl-9H-xanthen-9-one (14h) 
1H NMR (300 MHz, CDCl3) δ (ppm) 8.18 (dd, J = 7.8 Hz, 1.2 Hz, 1H), 8.11 (d, J = 
1.2 Hz, 1H), 7.55-7.41 (m, 3H), 7.27-7.22 (m, 1H), 2.55 (s, 3H), 2.47 (s, 3H); 13C NMR 
(75.5 MHz, CDCl3) δ (ppm) 177.6, 154.5, 154.3, 135.9, 135.5, 133.6, 127.2, 125.9, 
124.3, 123.2, 121.6, 121.2, 117.8, 20.8, 15.8. 
 
5-Ethyl-2-methyl-9H-xanthen-9-one (14i) 
1H NMR (300 MHz, CDCl3) δ (ppm) 8.19 (dd, J = 8.1 Hz, 1.5 Hz, 1H), 8.11 (d, J = 
1.2 Hz, 1H), 7.58-7.51 (m, 2H), 7.42 (d, J = 8.4 Hz, 1H), 7.29 (t, J = 7.5 Hz, 1H), 2.99 (q, 
J = 7.5 Hz, 2H), 2.47 (s, 3H), 1.36 (t, J = 7.5 Hz, 3H); 13C NMR (75.5 MHz, CDCl3) δ 
(ppm) 177.6, 154.3, 154.2, 135.9, 133.9, 133.6, 133.0, 125.9, 124.3, 123.3, 121.7, 121.2, 
117.8, 22.9, 20.8, 14.1. 
 
2-Methyl-5-propyl-9H-xanthen-9-one (14j) 
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1H NMR (300 MHz, CDCl3) δ (ppm) 8.20 (dd, J = 7.8 Hz, 1.5 Hz, 1H), 8.11 (d, J = 
0.9 Hz, 1H), 7.56-7.51 (m, 2H), 7.92 (d, J = 8.7 Hz, 1H), 7.30-7.25 (m, 1H), 2.93 (t, J = 
7.5 Hz, 2H), 2.47 (s, 3H), 1.84-1.69 (m, 2H), 1.03 (t, J = 7.2 Hz, 3H); 13C NMR (75.5 
MHz, CDCl3) δ (ppm) 177.6, 154.2, 135.9, 134.8, 133.6, 131.5, 125.9, 124.4, 123.2, 
121.7, 121.2, 117.7, 31.8, 23.0, 20.8, 14.0. 
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Chapter 5 
[4+1] Annulations of Alkynals via an Organocatalytic Double Michael Cascade 
 
5.1 Background 
Organocatalysis has emerged as a powerful approach to the construction of 
structurally diverse molecular architectures in the last decade.1 Aminocatalysis pioneered 
by Barbas, List, and MacMillan, has become the landmark of the field.2,3 A number of 
unprecedented organic transformations have been realized with the strategy. 
Furthermore, capitalizing on reversible iminium-enamine catalysis, many synthetically 
efficient catalytic cascade processes have been developed for the facile construction of 
complex molecular architectures.4 Notably, various cyclic ring structures ranging from 3 
to 7 membered sizes have been constructed.5 Despite these impressive achievements, to 
the best of our knowledge, there currently exists no amine catalyzed [4+1] annulation 
reaction to produce five-membered rings.6-8 Thus, the identification of an amine 
catalyzed [4+1] annulation that is general and operational simple remaines a prominent 
and challenging goal. Towards this end, herein we wish to report a catalytic platform for 
[4+1] annulation. Notably, the process involving an unprecedented conjugate addition-
protonation-conjuagte addition cascade sequence, is catalyzed by simple pyrrolidine 
using readily available N-tosyl-2-aminophenols and ynals as reactants under mild 
reaction conditions to give synthetically and biologically valuable benzoxazoles in high 
yield.9 
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Amine catalyzed 1,3-dipolar cycloaddition reactions for the formation of five-
membered rings have been subjected to intensively studies.10 In these approaches, α,β-
unsaturated aldehydes are genreally used as essential substrates through iminium 
activation with an amine promoter to react with 1,3-dipolar components such as 
nitrones11 and azomethine ylides12 in concerted or iminium-enamine stepwise process. In 
contrast, the otherwise inaccessible modality, [4+1] annulation offers an alternative 
versatile route to five-membered scaffolds because of their readily availability of starting 
materials. Nevertheless, survey of literature reveals that the only a handful 
organocatalyzed [4+1] annulation reactions are reported.6-8 Elegant examples include 
Kwon’s phosphine promoted6 and Xiao’s sulfur ylide7 [4+1] annulations. 
Although iminium catalysis with enals has enjoyed great success,3 reactions with 
ynals have emerged slowly. Limited examples of ynals in iminium catalysis have been 
reported.13,14 This may attribute to similar reaction behavior to enals people think while a 
non-stereogenic center generated in conjugate addition adducts diminishes synthetic 
interest. However, recent studies from our group and others reveal a number of 
interesting chemistries beyond original expection.13,14 We have developed unprecedented 
chiral allenamine cascade reactions for the facile assembly of important molecular 
architectues, which are difficult to achieve with enal-based reactions.   
5.2 Research Design 
In our continuing effort on this avenue, we proposed a new amine catalyzed [4+1] 
cyclization reaction (Scheme 5.1). Given the importance of benzoxazoles in synthesis 
and pharmaceuticals,9 we devised the biuncleophilic N-tosyl-2-aminophenol substrates 
(2) for the proposed [4+1] annulation reaction with ynals 1. It is hypothesized that 
activation of ynal 1 via iminium ion 4 renders the nucleophilic phenol –OH 2 conjugate 
attack the β-position. Protonation of the resulting allenamine 5 gives a new iminium ion 
6. Then an intramolecular conjugate addition proceeds to form a benzoxazole ring 3. 
Scheme 5.1 Proposed amine catalyzed [4+1] annulations 
 
Although the proposed reaction looks simple on paper, there are significant barriers 
to overcome. The first concern is the second conjugate reaction in the cascade. The 
significant steric hindrance induced by β,β’-disubstituted enals renders the conjugate 
addition difficult. It is even more difficult with bulky protected “N” nucleophile. It 
should be noted that the examples of β,β’-disubstituted enals in aminocatalyzed 
conjugate additions are scarce.15 Moreover, the “O” added adduct 5 significantly reduce 
the reactivity for the second conjugate addition reaction due to the formation of a 
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deactivated electron-rich enol ether. Third, a condensation reaction between the highly 
active aldehyde 1 and 2 could compete with the proposed [4+1] process. 
5.3 Optimization of Reaction Conditions 
To test the validity of our proposed organocatalytic [4+1] annulation process, we 
probed a model reaction of ynal 1a with N-tosyl-2-aminophenol (2a) in the presence of 
simple pyrrolidine (20 mol %) as a promoter, which can readily engage in iminium 
formation with aldehyde functionality in ynal 1a (Table 5.1). To our delight, pyrrolidine 
readily effects the [4+1] annulation reaction. The reaction proceeded smoothly to afford 
the desired benzoxazole 3a in 5 min with good yield (75%, entry 1). Furthermore, under 
the reaction condition, we did not observe condensation product between aldehyde 1a 
and N-tosyl-2-aminophenol (2a). It is believed that under the mild non-acidic condition, 
it is difficult to form the product, whose formation is required an acid promoter. In 
addition, it appears that the second conjugate addition reaction went smoothly. The 
reason for this may be because the intramolecular process. With pyrrolidine as catalyst, 
we examined the solvent effect on the process (entries 2-5).  Dichloroethane (DCE) was 
identified as optimal reaction medium for the reaction (entry 5). In this instance, the 
reaction was accomplished in 5 min to produce product 3a in 84% yield. Furthermore, 
notably, lowering catalyst loading to 5 mol % gave even higher yield (93%) of the 
product formed despite prolonging reaction time (15 h) (entry 6). The increase of the 
yield could be explained by minimization of undesired aldol reaction between product 3a 
and reactant 1a, which was observed with 20 mol % catalyst loading. Importantly, no 
product was observed when a background reaction was carried out without any catalyst 
(entry 7). Besides, TEA failed to promote the reaction indicating that the [4+1] 
annulation reaction did not proceed via base-catalyzed process (entry 8). 
Table 5.1 Optimization of Reaction Conditions[a] 
 
entry cat. (mol %) solvent t % 
yield[b] 
1 pyrrolidine (20) CH2Cl2 5 min 75 
2 pyrrolidine (20) CHCl3 5 min 73 
3 pyrrolidine (20) CH3CN 5 min 69 
4 pyrrolidine (20) toluene 5 min 61 
5 pyrrolidine (20) Cl(CH2)2Cl 5 min 84 
6 pyrrolidine (5) Cl(CH2)2Cl 15 h 93 
7 none CH2Cl2 1 h 0 
8 TEA CH2Cl2 1 h 0 
[a] Reactions were carried out with 1a (0.1 mmol) and 2a (0.11 mmol) at rt in 0.2 mL of 
solvent.  [b] Isolated yields. 
5.4 Expansion of Substrate Scope  
The simple pyrrolidine catalyzed [4+1] annulation reaction serves as a general 
approach to structurally diverse benzoxazoles under mild reaction conditions (Table 5.2). 
The examination of the substrate scope of reactants ynals 1 has revealed a significant 
tolerance (entries 1-16). In addition unsubstituted ynal (entry 1), the aromatic ring 
bearing electron-withdrawing (entries 2-6) and –donating (entries 7-9) can be applied for 
the protocol. In all cases, uniformly high yields (85-93%) are achieved.  
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Table 5.2 Scope of Pyrrolidine Catalyzed [4+1] Annulation Reactions[a] 
+
pyrrolidine
(5 mol %)
N
Ts
O
R CHO
R
O
DCE, rt, 15 h
21 3
X X
1
3
5 OH
NHTs
 
entry R, X 3 % 
yield[b] 
1 Ph, H 3a 93 
2 4-FC6H4, H 3b 88 
3 4-ClC6H4, H 3c 95 
4 4-BrC6H4, H 3d 92 
5 4-NO2C6H4, H 3e 89 
6 4-CNC6H4, H 3f 85 
7 4-MeC6H4, H 3g 93 
8 4-MeOC6H4, H 3h 86 
9 3-MeC6H4, H 3i 91
10 BnOCH2, H 3j 88
11 2-thienyl, H 3k 91 
12c Ph, 4-Me 3l 91 
13c Ph, 5-Me 3m 89 
14c Ph, 4-t-Bu 3n 83 
15c Ph, 4-Cl 3o 87 
16c Ph, 4-NO2 3p 84 
17c 4-ClC6H4, 4-Me 3q 92 
18c 4-NO2C6H4, 4-Cl 3r 90 
[a] Reaction conditions: unless specified, see footnote a in Table 1.  [b] Isolated yields.  
c With pyrrolidine (0.020 mmol) at 40 °C for 24 h. 
Furthermore, the pyrrolidine promoted process can be extended to aliphatic (entry 
10) and heterocyclic (entry 11) ynals with high efficiency.  Structural variation of N-
tosyl-2-aminophenols is then probed (entries 12-18).  The catalytic system is generally 
applicable to a variety of N-tosyl-2-aminophenols under the optimized conditions.  
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Again, high yields (83-92%) are achieved in these examples.  However, interestingly it 
appears that the substituents on the aromatic system have impact on the reaction.  The 
rate of conversion with these substrates is noticeably slower than without substituents no 
matter what the electron-donating (entries 12-14, and 17), and withdrawing groups are 
attached (entries 15-17 and 18).  Therefore, the corresponding reactions are carried out 
with 20 mol % catalyst and at 40 °C for 24 h to facilitate these transformations. 
5.5 Application 
In addition, the pyrrolidine catalyzed [4+1] annulation reaction can be applied with 
Boc-protected 2-aminophenols 10 (Scheme 5.2, Eq. 1). Under similar reaction conditions 
with 20 mol % catalyst, the process proceeded smoothly to afford the desired product 10 
in 91% yield. The [4+1] annulation product 11 can be deprotected to give 12 by reduction 
with LiAlH4 in 82% yield (Eq. 2).  
Scheme 5.2 Synthetic Elaboration of [4+1] Annulation Products 
 
Furthermore, reduction of 11 to alcohol by NaBH4 followed by the treatment with 
TBAF afforded the cyclization product 13 in 79% yield in 2-step transformation (Eq. 3).  
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5.6 Discussion 
Having demonstrated a simple pyrrolidine catalyzed [4+1] annulation reaction of 
ynals with N-tosyl/Boc-2-aminophenols, weattempted to probe a catalytic 
enantioselective version with a chiral organocatalyst (Table 5.3).  Disappointedly, very 
poor ees were observed in these cases. 
Table 5.3 Exploration of enantioselective [4+1] annulations[a] 
+ cat. (20 mol%)
N
Ts
O
Ph CHO
Ph
O
CH2Cl2, rt
2a1a 3a
OH
NHTs
N
H
Ph
OTMS
Ph N
H
Ph
OTES
Ph
II
N
H
Ph
OTBS
Ph
III
N
H
Ph Ph
N
N
H
t-Bu
O
Bn NH OH
Ph
Ph N
H
NHTf N
N
H
CO2HBn
cat.
I IV
V VI VII VIII  
 
Entry Cat. t Yield (%)[b] ee (%)[c] 
1 I 10 min 93 2 
2 II 10 min 90 3 
3 III 10 min 92 3 
4 IV 15 h 85 2 
5 V 15 h 87 3 
6 VI 15 h 82 0 
7 VII 15 h 80 0 
8 VIII 15 h 0 ndd 
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[a] Reaction conditions: unless specified, reactions were carried out with 1a (0.1 mmol) 
and 2a (0.11 mmol) at rt in 0.2 mL of solvent in the presence of a catalyst (0.02 mmol).  
[b] Isolated yields.  [c] Determined by chiral HPLC analysis. 
Scheme 5.3 Rationalization of Low Enantioselectivity of Chiral Amine Catalyzed [4+1] 
Annulation 
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The observed results could be rationalized in the proposed model (Scheme 3).  
The “O”-centered nucleophilic species in 2 is involved in the first conjugate addition (see 
below preliminary mechanic study).  The nucleophilic addition could proceed in two 
possible ways a and b due to the linear geometry of the C≡C triple bond and lead to 
respective adducts 14 and 15.  Compound 14 is believed to be formed more favorably 
since the “O” attacks the less steric side of a chiral amine derived iminium ion 13.  
Furthermore, the bulky NHTs moiety in 14 and 15 are oriented in position to minimize 
the interaction with big side chain of the catalyst.  The new stereogenic center is created 
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in the second conjugate addition.  However, the chiral center of the catalyst (e.g., 14 and 
15) is far away from the conjugate addition reaction center in both cases.  Accordingly, 
it is expected that poor enantiocontrol is observed in both chiral iminiums 14 and 15.  
This is also evidenced in chiral amine catalyzed nuelcophilic conjugate addition of β,β’-
disubstituted α,β-unsaturated aldehydes.  A very limited number of examples in 
achieving good enantioselectivity have been reported.15 
Table 5.4 Addition Sequence Tests of [4+1] Annulation Reactions[a] 
 
entry PhOH PhNHTs % 
yield[b] 
% 
yield[b] 
1 1.1 equiv 0.0 equiv 92 0 
2 0.0 equiv 1.1 equiv 0 0 
3 1.1 equiv 1.1 equiv 90 0 
[a] Reaction condition: a mixture of PhOH (0.11 mmol) and/or PhNHTs (0.11 mmol), 1a 
(0.1 mmol) and pyrrolidine (0.005 mmol) in 0.5 mL of DCE was stirred at rt for 15 h. 
[b]Isolated yields. 
Although the addition sequence of “O” and “N” nucleophiles does not affect the 
structures of reaction products, the studies may help to understand their nucleophilic 
nature. Furthermore, such insight may also assist us to develop asymmetric version of the 
process. Under the same reaction conditions we employed above (Table 5.4), we 
performed the conjugate addition reactions of alkynal 1a with PhOH or PhNHTs, 
respectively. Oxo-conjugate addition adduct 16 was formed in 92% yield (entry 1), while 
no detectable aza-conjugate addition product 17 was observed (entry 2). The competition 
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reaction between PhOH and PhNHTs furthermore confirmed that the O nucleophile in 1 
should be added to alkynals firstly (entry 3). The “O” addition occurred first may be due 
to its less hindrance. The results could help us to develop asymmetric synthesis of 
enantioenriched benzoxazoles where the 2nd conjugate addition is responsible for the 
formation of stereogenic center. 
Conclusion 
In conclusion, we have designed and implemented an unprecedented amine-
catalyzed [4+1] annulation reaction. The notable features of the process include a new 
conjugate addition-protonation-conjugate addition cascade sequence by employing 
readily available ynals and N-protected-2-aminophenols as reactants. Moreover, an 
iminium-allenamine-iminium activation mode promoted by simple pyrrolidine is reported 
for the first time. The mild reaction protocol allows for a broad spectrum of ynals and 2-
aminophenols to engage in the cascade sequence with high efficiency. Furthermore, 
synthetically and biologically important benzoxazoles are created in one-pot operation. 
The development of enantioselective [4+1] annulation reactions for the formation of 
enantioenriched benzoxazoles and expansion of the activation mode using underexplored 
ynals in aminocatalysis are being pursued in our laboratory. 
Experimental Section 
Preparation and physical and spectroscopic data for substrates 2a-2f and 9 
Substrates 2a-2f16 and 917 were prepared according to the literature reported 
procedure. 
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N-(2-Hydroxyphenyl)-4-methylbenzenesulfonamide (2a) 
The title compound was obtained in 92% yield as white solid. M. P. 139-140 ºC; 1H 
NMR (300 MHz, DMSO-d6) δ (ppm) 9.55 (s, 1H), 9.13 (s, 1H), 7.64 (d, J = 8.1 Hz, 2H), 
7.29 (d, J = 8.1 Hz, 2H), 7.16 (dd, J = 7.8 Hz, 1.2 Hz 1H), 6.95-6.89 (m, 1H), 6.75-6.66 
(m, 2H), 2.32 (s, 3H); 13C NMR (75.5 MHz, DMSO-d6) δ (ppm) 150.1, 142.8, 137.8, 
129.3, 126.8, 126.1, 124.4, 124.2, 119.0, 115.6, 21.0. 
 
N-(2-Hydroxy-5-methylphenyl)-4-methylbenzenesulfonamide (2b) 
The title compound was obtained in 87% yield as grey solid. M. P. 146-147 ºC; 1H 
NMR (300 MHz, DMSO-d6) δ (ppm) 9.33 (bs, 1H), 9.03 (s, 1H), 7.62 (d, J = 7.5 Hz, 
2H), 7.29 (d, J = 7.8 Hz, 2H), 6.97 (d, J = 1.8 Hz, 1H), 6.72 (dd, J = 8.1 Hz, 1.5 Hz, 1H), 
6.60 (d, J = 8.1 Hz, 1H), 2.32 (s, 3H), 2.11 (s, 3H); 13C NMR (75.5 MHz, DMSO-d6) δ 
(ppm) 147.8, 142.9, 137.8, 129.4, 127.6, 126.9, 126.6, 124.9, 123.9, 115.4, 21.1, 20.3. 
 
N-(2-Hydroxy-4-methylphenyl)-4-methylbenzenesulfonamide (2c) 
The title compound was obtained in 82% yield as white solid. M. P. 105-106 ºC; 1H 
NMR (300 MHz, CDCl3) δ (ppm) 7.60 (d, J = 8.1 Hz, 2H), 7.17 (d, J = 8.1 Hz, 2H), 6.86 
(bs, 1H), 6.72-6.68 (m, 3H), 6.49 (dd, J = 8.1 Hz, 1.2 Hz 1H), 2.34 (s, 3H), 2.18 (s, 3H); 
13C NMR (75.5 MHz, CDCl3) δ (ppm) 150.4, 144.2, 138.5, 135.0, 130.0, 127.6, 125.5, 
121.6, 120.2, 117.4, 21.6, 21.1. 
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 N-(5-(tert-Butyl)-2-hydroxyphenyl)-4-methylbenzenesulfonamide (2d) 
The title compound was obtained in 84% yield as pink solid. M. P. 107-108 ºC; 1H 
NMR (300 MHz, CDCl3) δ (ppm) 7.59 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 8.1 Hz, 2H), 7.08 
(dd, J = 8.7 Hz, 2.4 Hz, 1H), 6.85 (d, J = 8.4 Hz, 1H), 6.58 (d, J = 2.4 Hz, 1H), 6.35 (bs, 
1H), 6.29 (s, 1H), 2.38 (s, 3H), 1.08 (s, 9H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 
149.0, 144.4, 144.0, 134.7, 129.7, 127.9, 125.4, 123.6, 122.0, 116.6, 34.0, 31.3, 21.7. 
 
N-(5-Chloro-2-hydroxyphenyl)-4-methylbenzenesulfonamide (2e) 
The title compound was obtained in 87% yield as pink solid. M. P. 189-190 ºC; 1H 
NMR (300 MHz, DMSO-d6) δ (ppm) 9.93 (s, 1H), 9.44 (s, 1H), 7.65 (d, J = 8.1 Hz, 2H), 
7.33 (d, J = 7.8 Hz, 2H), 7.16 (d, J = 2.7 Hz, 1H), 6.96 (dd, J = 8.7 Hz, 2.7 Hz, 1H), 6.73 
(d, J = 8.4 Hz, 1H), 2.34 (s, 3H); 13C NMR (75.5 MHz, DMSO-d6) δ (ppm) 148.9, 143.1, 
137.4, 129.5, 126.7, 125.7, 125.5, 123.4, 122.0, 116.7, 21.0. 
 
N-(2-Hydroxy-5-nitrophenyl)-4-methylbenzenesulfonamide (2f) 
The title compound was obtained in 85% yield as yellow solid. M. P. 202-203 ºC; 
1H NMR (300 MHz, DMSO-d6) δ (ppm) 11.48 (bs, 1H), 9.80 (bs, 1H), 8.07 (d, J = 2.1 
Hz, 1H), 7.89 (dd, J = 9.0 Hz, 2.4 Hz, 1H), 7.66 (d, J = 7.8 Hz, 2H), 7.33 (d, J = 7.8 Hz, 
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2H), 6.90 (d, J = 9.0 Hz, 1H), 2.32 (s, 3H); 13C NMR (75.5 MHz, DMSO-d6) δ (ppm) 
156.6, 143.5, 139.3, 137.3, 129.7, 126.9, 125.1, 122.4, 119.1, 115.4, 21.1. 
 
tert-Butyl (2-hydroxyphenyl)carbamate (9) 
The title compound was obtained in 95% yield as yellow solid. M. P. 141-143 ºC; 
1H NMR (500 MHz, CDCl3) δ (ppm) 8.21 (bs, 1H), 7.12 (d, J = 8.0 Hz, 1H), 7.02 (t, J = 
7.5 Hz, 1H), 6.95 (d, J = 8.0 Hz, 1H), 6.85 (t, J = 7.5 Hz, 1H), 6.74 (s, 1H), 1.53 (s, 9H); 
13C NMR (125 MHz, CDCl3) δ (ppm) 155.1, 147.4, 125.7, 125.6, 121.4, 120.9, 118.8, 
82.2, 28.4. 
General Procedure for Organocatalytic [4+1] Annulations 
+
Pyrrolidine
N
Ts
O
Ph CHO
Ph
O
DCE, rt, 15 h
1a 2a 3a
OH
NHTs
 
To a solution of 2a (29 mg, 0.11 mmol) in 0.5 mL DCE were added pyrrolidine 
(0.4 uL, 0.005 mmol) and 1a (13.5 μL, 0.1 mmol) at room temperature. The mixture was 
stirred at room temperature for 15 h. Then the mixture was applied to column 
chromatography directly and eluted with ethyl acetate and hexane to give product 3a 
(36.4 mg, 93% yield) as a yellow solid. 
Physical and Spectroscopic Data for Organocatalytic [4+1] Annulation Products 
 
2-(2-Phenyl-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3a) 
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The title compound was prepared according to the general procedure in 93% yield 
as yellow solid. M. P. 127-128 ºC; 1H NMR (300 MHz, CDCl3) δ (ppm) 9.72 (dd, J = 3.0 
Hz, 2.1 Hz, 1H), 7.57-7.54 (m, 1H), 7.41-7.36 (m, 2H), 7.34-7.31 (m, 1H), 7.26-7.19 (m, 
2H), 7.07-6.95 (m, 6H), 6.89-6.86 (m, 1H), 3.77 (dd, J = 16.5 Hz, 3.3 Hz, 1H), 3.69 (dd, 
J = 16.5 Hz, 1.8 Hz, 1H), 2.30 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 198.3, 
148.9, 144.1, 136.7, 136.5, 130.0, 129.5, 128.4, 127.4, 126.6, 124.6, 122.5, 113.8, 109.6, 
102.0, 51.9, 21.6.  
 
2-(2-(4-Fluorophenyl)-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3b) 
The title compound was prepared according to the general procedure in 88% yield 
as yellow oil. 1H NMR (300 MHz, CDCl3) δ (ppm) 9.71 (dd, J = 3.0 Hz, 2.1 Hz, 1H), 
7.60-7.57 (m, 1H), 7.39-7.34 (m, 2H), 7.12-6.99 (m, 6H), 6.90-6.85 (m, 3H), 3.77-3.64 
(m, 2H), 2.33 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 197.9, 148.6, 144.3, 136.7, 
132.7, 129.6, 129.5, 129.4, 126.4, 124.7, 122.7, 115.4, 115.1, 113.9, 109.7, 101.4, 52.0, 
21.6. 
N
Ts
O O
Cl  
2-(2-(4-Chlorophenyl)-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3c) 
The title compound was prepared according to the general procedure in 95% yield 
as colorless oil. 1H NMR (300 MHz, CDCl3) δ (ppm) 9.71 (t, J = 2.4 Hz, 1H), 7.61-7.58 
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(m, 1H), 7.31-7.26 (m, 2H), 7.16-6.97 (m, 8H), 6.90-6.87 (m, 1H), 3.76-3.64 (m, 2H), 
2.34 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 197.7, 148.6, 144.4, 136.7, 136.3, 
135.2, 129.5, 129.4, 128.8, 128.5, 126.4, 124.7, 122.7, 113.9, 109.7, 101.3, 51.7, 21.6. 
 
2-(2-(4-Bromophenyl)-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3d) 
The title compound was prepared according to the general procedure in 92% yield 
as colorless oil. 1H NMR (500 MHz, CDCl3) δ (ppm) 9.71 (t, J = 2.0 Hz, 1H), 7.62-7.60 
(m, 1H), 7.29 (d, J = 9.0 Hz, 2H), 7.21 (d, J = 8.5 Hz, 2H), 7.10 (d, J = 8.5 Hz, 2H), 7.04-
6.98 (m, 4H), 6.89-6.87 (m, 1H), 3.70 (d, J = 2.0 Hz, 2H), 2.35 (s, 3H); 13C NMR (125 
MHz, CDCl3) δ (ppm) 197.7, 148.6, 144.4, 136.6, 135.6, 131.4, 129.5, 129.4, 129.0, 
126.3, 124.7, 124.6, 122.8, 113.9, 109.7, 101.3, 51.7, 21.7. 
 
2-(2-(4-Nitrophenyl)-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3e) 
The title compound was prepared according to the general procedure in 89% yield 
as colorless oil. 1H NMR (300 MHz, CDCl3) δ (ppm) 9.68 (dd, J = 2.4 Hz, 1.8 Hz, 1H), 
8.03 (d, J = 9.0 Hz, 2H), 7.63-7.59 (m, 3H), 7.19 (d, J = 8.4 Hz, 2H), 7.10-7.00 (m, 4H), 
6.94-6.91 (m, 1H), 3.79 (dd, J = 16.5 Hz, 2.7 Hz, 1H), 3.72 (dd, J = 16.5 Hz, 1.8 Hz, 1H), 
2.33 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 196.7, 148.6, 148.5, 145.0, 143.4, 
136.6, 129.7, 129.2, 128.3, 126.3, 125.2, 123.4, 123.1, 114.4, 110.0, 100.7, 51.2, 21.6. 
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 4-(2-(2-Oxoethyl)-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)benzonitrile (3f) 
The title compound was prepared according to the general procedure in 85% yield 
as yellow oil. 1H NMR (300 MHz, CDCl3) δ (ppm) 9.67 (t, J = 2.1 Hz, 1H), 7.60-7.49 
(m, 5H), 7.16 (d, J = 8.4 Hz, 2H), 7.08-6.99 (m, 4H), 6.92-6.89 (m, 1H), 3.72 (t, J = 3.0 
Hz, 2H), 2.36 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 196.9, 148.6, 144.9, 141.7, 
136.6, 132.1, 129.8, 129.2, 128.0, 126.4, 125.2, 123.1, 114.3, 113.8, 109.9, 100.9, 51.2, 
29.8, 21.7. 
 
2-(2-(p-Tolyl)-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3g) 
The title compound was prepared according to the general procedure in 93% yield 
as yellow solid. M. P. 95-96 ºC; 1H NMR (300 MHz, CDCl3) δ (ppm) 9.72 (dd, J = 3.0 
Hz, 1.8 Hz, 1H), 7.58-7.55 (m, 1H), 7.24 (dd, J = 6.6 Hz, 1.8 Hz, 2H), 7.07 (dd, J = 6.6 
Hz, 1.8 Hz, 1H), 7.03-6.93 (m, 6H), 6.88-6.85 (m, 1H), 3.77 (dd, J = 16.5 Hz, 3.0 Hz, 
1H), 3.66 (dd, J = 16.5 Hz, 1.8 Hz, 1H), 2.33 (s, 3H), 2.31 (s, 3H); 13C NMR (75.5 MHz, 
CDCl3) δ (ppm) 198.5, 148.9, 143.9, 140.1, 136.7, 133.8, 129.6, 129.3, 128.9, 127.3, 
126.6, 124.5, 122.4, 113.7, 109.5, 102.0, 51.9, 21.6, 21.3. 
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 2-(2-(4-Methoxyphenyl)-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3h) 
The title compound was prepared according to the general procedure in 86% yield 
as yellow solid. M. P. 134-135 ºC; 1H NMR (300 MHz, CDCl3) δ (ppm) 9.72 (dd, J = 3.3 
Hz, 1.8 Hz, 1H), 7.59-7.56 (m, 1H), 7.28-7.24 (m, 2H), 7.08 (d, J = 8.4 Hz, 2H), 7.01-
6.85 (m, 5H), 6.68 (d, J = 9.0 Hz, 2H), 3.80 (s, 3H), 3.74 (dd, J = 16.5 Hz, 3.3 Hz, 1H), 
3.66 (dd, J = 16.5 Hz, 1.8 Hz, 1H), 2.31 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 
198.5, 160.8, 148.7, 143.9, 136.8, 133.8, 129.5, 129.3, 129.0, 128.6, 126.6, 124.4, 122.4, 
113.7, 113.5, 109.6, 102.0, 55.5, 52.1, 21.6. 
 
2-(2-(m-Tolyl)-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3i) 
The title compound was prepared according to the general procedure in 91% yield 
as yellow oil. 1H NMR (300 MHz, CDCl3) δ (ppm) 9.73 (dd, J = 3.3 Hz, 2.1 Hz, 1H), 
7.61-7.58 (m, 1H), 7.26-7.22 (m, 1H), 7.18-7.10 (m, 2H), 7.06-6.86 (m, 8H), 3.75 (dd, J 
= 16.5 Hz, 3.3 Hz, 1H), 3.67 (dd, J = 16.5 Hz, 1.8 Hz, 1H), 2.31 (s, 3H), 2.13 (s, 3H); 13C 
NMR (75.5 MHz, CDCl3) δ (ppm) 198.4, 148.9, 143.9, 138.3, 136.6, 136.2, 130.7, 129.6, 
129.3, 128.2, 128.0, 126.5, 124.7, 124.5, 122.5, 113.8, 109.6, 102.0, 52.0, 21.5, 21.3. 
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2-(2-((Benzyloxy)methyl)-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3j) 
The title compound was prepared according to the general procedure in 88% yield 
as yellow oil. 1H NMR (300 MHz, CDCl3) δ (ppm) 9.69 (dd, J = 3.0 Hz, 1.8 Hz, 1H), 
7.76 (dd, J = 6.6 Hz, 1.5 Hz, 2H), 7.41-7.13 (m, 8H), 6.95-6.79 (m, 3H), 4.48 (s, 2H), 
3.93 (s, 2H), 3.28 (dd, J = 16.5 Hz, 3.0 Hz, 1H), 3.20 (dd, J = 16.5 Hz, 1.8 Hz, 1H), 2.35 
(s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 197.3, 148.5, 144.9, 137.3, 137.1, 130.0, 
128.5, 127.9, 127.6, 127.1, 124.3, 122.0, 112.9, 109.7, 102.8, 73.8, 72.7, 48.4, 21.7. 
 
2-(2-(Thiophen-2-yl)-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3k) 
The title compound was prepared according to the general procedure in 91% yield 
as yellow solid. M. P. 115-116 ºC; 1H NMR (300 MHz, CDCl3) δ (ppm) 9.75 (t, J = 2.4 
Hz, 1H), 7.54-7.51 (m, 1H), 7.29-7.19 (m, 4H), 7.04-6.85 (m, 6H), 3.74 (d, J = 2.4 Hz, 
2H), 2.32 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 197.7, 147.8, 144.1, 140.6, 
136.5, 129.5, 129.2, 129.0, 128.3, 126.9, 126.6, 124.4, 122.7, 113.5, 109.8, 100.0, 53.2, 
21.6. 
 
2-(5-Methyl-2-phenyl-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3l) 
The title compound was prepared according to the general procedure in 91% yield 
as yellow solid. M. P. 167-168 ºC; 1H NMR (300 MHz, CDCl3) δ (ppm) 9.71 (dd, J = 2.7 
Hz, 2.1 Hz, 1H), 7.38-7.37 (m, 3H), 7.35-7.29 (m, 1H), 7.23-7.18 (m, 2H), 7.06 (d, J = 
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8.4 Hz, 2H), 6.96 (d, J = 8.1 Hz, 2H), 6.80 (dd, J = 8.1 Hz, 0.9 Hz, 1H), 6.75 (d, J = 8.1 
Hz, 1H), 3.74 (dd, J = 16.5 Hz, 3.0 Hz, 1H), 3.67 (dd, J = 16.5 Hz, 2.1 Hz, 1H), 2.35 (s, 
3H), 2.30 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 198.4, 146.8, 144.0, 136.8, 
136.7, 132.3, 130.0, 129.4, 128.4, 127.3, 126.5, 124.7, 114.5, 109.1, 102.0, 51.8, 21.6, 
21.5. 
 
2-(6-Methyl-2-phenyl-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3m) 
The title compound was prepared according to the general procedure in 89% yield 
as yellow oil. 1H NMR (300 MHz, CDCl3) δ (ppm) 9.70 (dd, J = 2.7 Hz, 2.1 Hz, 1H), 
7.44-7.37 (m, 3H), 7.35-7.29 (m, 1H), 7.23-7.18 (m, 2H), 7.06 (d, J = 8.4 Hz, 2H), 6.95 
(d, J = 8.1 Hz, 2H), 6.77 (dd, J = 8.1 Hz, 0.9 Hz, 1H), 6.70 (s, 1H), 3.73 (dd, J = 16.2 Hz, 
2.7 Hz, 1H), 3.63 (dd, J = 16.5 Hz, 2.1 Hz, 1H), 2.31 (s, 3H), 2.30 (s, 3H); 13C NMR 
(75.5 MHz, CDCl3) δ (ppm) 198.3, 149.0, 143.9, 136.8, 136.6, 134.9, 129.9, 129.4, 
128.4, 127.3, 127.1, 126.6, 122.7, 113.6, 110.4, 102.0, 51.8, 21.6, 21.4. 
 
2-(5-(tert-Butyl)-2-phenyl-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3n) 
The title compound was prepared according to the general procedure in 83% yield 
as brown solid. M. P. 148-149 ºC; 1H NMR (300 MHz, CDCl3) δ (ppm) 9.72 (s, 1H), 
7.60 (s, 1H), 7.40 (d, J = 4.8 Hz, 1H), 7.34 (t, J = 4.2 Hz, 2H), 7.23 (t, J = 4.5 Hz, 2H), 
7.04-6.99 (m, 3H), 6.96 (d, J = 4.8 Hz, 2H), 6.77 (d, J = 4.8 Hz, 1H), 3.73 (dd, J = 9.6 
108 
 
Hz, 1.8 Hz, 2H), 2.30 (s, 3H), 1.35 (s, 9H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 198.5, 
146.8, 145.9, 144.0, 136.9, 136.5, 129.9, 129.4, 129.1, 128.4, 127.5, 126.7, 121.0, 111.5, 
108.5, 102.3, 52.0, 35.0, 31.7, 21.6. 
 
2-(5-Chloro-2-phenyl-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3o) 
The title compound was prepared according to the general procedure in 87% yield 
as yellow solid. M. P. 163-164 ºC; 1H NMR (300 MHz, CDCl3) δ (ppm) 9.71 (dd, J = 3.0 
Hz, 1.8 Hz, 1H), 7.55 (d, J = 2.1 Hz, 1H), 7.37-7.33 (m, 3H), 7.25-7.20 (m, 2H), 7.06-
6.95 (m, 5H), 6.78 (d, J = 8.4 Hz, 1H), 3.78 (dd, J = 16.5 Hz, 3.0 Hz, 1H), 3.69 (dd, J = 
16.5 Hz, 1.8 Hz, 1H), 2.32 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 197.8, 147.5, 
144.4, 136.2, 130.7, 130.2, 129.6, 128.5, 127.5, 127.4, 126.6, 124.1, 117.2, 113.9, 110.1, 
103.1, 51.8, 21.7. 
 
2-(5-Nitro-2-phenyl-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde (3p) 
The title compound was prepared according to the general procedure in 84% yield 
as brown oil. 1H NMR (300 MHz, CDCl3) δ (ppm) 9.71 (dd, J = 2.7 Hz, 1.8 Hz, 1H), 
8.34 (d, J = 2.4 Hz, 1H), 8.01 (dd, J = 8.7 Hz, 2.4 Hz, 1H), 7.43-7.24 (m, 5H), 7.06-6.98 
(m, 4H), 6.93 (d, J = 9.0 Hz, 1H), 3.89 (dd, J = 16.8 Hz, 2.7 Hz, 1H), 3.81 (dd, J = 16.8 
Hz, 1.8 Hz, 1H), 2.32 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 196.8, 153.7, 144.9, 
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143.4, 135.6, 135.5, 130.8, 130.6, 129.7, 128.7, 127.2, 126.8, 121.7, 108.7, 108.6, 104.7, 
51.7, 21.7. 
 
2-(2-(4-Chlorophenyl)-5-methyl-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-
yl)acetaldehyde (3q) 
The title compound was prepared according to the general procedure in 92% yield 
as yellow solid. M. P. 92-93 ºC; 1H NMR (300 MHz, CDCl3) δ (ppm) 9.69 (s, 1H), 7.43 
(s, 1H), 7.28 (d, J = 8.4 Hz, 2H), 7.12 (d, J = 9.3 Hz, 4H), 7.02 (d, J = 8.1 Hz, 2H), 6.82 
(d, J = 8.1 Hz, 1H), 6.76 (d, J = 8.1 Hz, 1H), 3.67 (d, J = 1.8 Hz, 2H), 2.36 (s, 3H), 2.34 
(s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 197.9, 146.6, 144.3, 136.8, 136.2, 135.3, 
132.6, 129.5, 129.4, 128.7, 128.4, 126.3, 124.9, 114.6, 109.2, 101.4, 51.7, 21.6, 21.5. 
 
2-(5-Chloro-2-(4-nitrophenyl)-3-tosyl-2,3-dihydrobenzo[d]oxazol-2-yl)acetaldehyde 
(3r) 
The title compound was prepared according to the general procedure in 90% yield 
as yellow solid. M. P. 152-153 ºC; 1H NMR (300 MHz, CDCl3) δ (ppm) 9.67 (dd, J = 2.7 
Hz, 1.8 Hz, 1H), 8.05 (t, J = 2.1 Hz, 1H), 8.02 (t, J = 2.1 Hz, 1H), 7.60 (d, J = 2.1 Hz, 
1H), 7.58 (t, J = 2.1 Hz, 1H), 7.56 (t, J = 2.1 Hz, 1H), 7.17 (dd, J = 6.6 Hz, 1.5 Hz, 2H), 
7.05-7.01 (m, 3H), 6.84 (d, J = 8.7 Hz, 1H), 3.83 (dd, J = 16.5 Hz, 2.4 Hz, 1H), 3.73 (dd, 
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J = 16.5 Hz, 1.5 Hz, 1H), 2.35 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 196.2, 
148.7, 147.2, 145.4, 142.8, 136.3, 130.5, 129.8, 128.3, 128.2, 126.3, 124.8, 123.5, 114.5, 
110.5, 101.8, 51.1, 21.7. 
Preparation and Physical and Spectroscopic Data for 11-13 
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2-(2-Phenyl-2,3-dihydrobenzo[d]oxazol-2-yl)ethanol (11) 
According to the general procedure for the [4+1] annulations, 10 was prepared in 
91% yield and subjected to the following reactions. First, 10 (31 mg, 0.09 mmol) was 
dissolved in 5 mL THF and the mixture was cooled to 0 ºC. LiAlH4 (9.5 mg, 0.25 mmol) 
was added slowly to the above mixture. After stirring for 1 h, the reaction was quenched 
by addition of 0.5 mL water. Then the mixture was passed through a short pad of celite 
and washed with DCM. The liquid was dried with Na2SO4 and was evaporated to give a 
crude mixture. The mixture was applied to column chromatography to give 11 as red 
solid. M. P. 97-98 ºC; 1H NMR (300 MHz, CDCl3) δ (ppm) 7.32-7.25 (m, 4H), 7.20 (t, J 
= 7.0 Hz, 1H), 6.67 (q, J = 7.5 Hz, 2H), 6.56 (t, J = 7.5 Hz, 1H), 6.46 (d, J = 8.0 Hz, 1H), 
4.55 (t, J = 6.5 Hz, 1H), 4.55 (bs, 1H), 3.85-3.77 (m, 2H), 2.07-2.05 (m, 2H); 13C NMR 
(75.5 MHz, CDCl3) δ (ppm) 144.1, 143.5, 136.0, 128.8, 127.2, 126.4, 121.4, 118.3, 
114.7, 114.0, 61.0, 57.2, 40.5. 
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 4α-Phenyl-4,4α-dihydrobenzo[4,5]oxazolo[3,2-c][1,3]oxazin-1(3H)-one (12) 
To a mixture of 10 (34 mg, 0.1 mmol) in MeOH (2 mL) was added NaBH4 (7.6 mg, 
0.2 mmol) at 0 ºC. The mixture was stirred for 1 h at 0 ºC, and quenched with 5 mL of 
water. The product was extracted with ethyl acetate and the organic layer was dried with 
Na2SO4. Pure reduced product was obtained in 100% yield after evaporation of the 
solvent. The reduced product was dissolved in 3 mL THF, and treated with 1M TBAF in 
THF (0.5 mL, 0.5 mmol). After stirring for 2 h, the reaction was quenched with water (10 
mL). The product was extracted with ethyl acetate. The organic layer was dried with 
Na2SO4 and evaporated to give the crude mixture which was purified by column 
chromatography to give 12 as pink solid. M. P. 84-85 ºC; 1H NMR (300 MHz, CDCl3) δ 
(ppm) 8.00-7.97 (m, 2H), 7.49-7.38 (m, 4H), 7.18-7.04 (m, 3H), 4.66 (t, J = 5.7 Hz, 2H), 
3.15 (t, J = 5.7 Hz, 2H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 168.4, 149.8, 141.0, 
139.1, 130.6, 129.6, 128.7, 128.6, 127.2, 127.0, 124.1, 121.6, 75.9, 32.9. 
 
(E)-3-Phenoxy-3-phenylacrylaldehyde (16) 
To a solution of PhOH (10 mg, 0.11 mmol) in 0.5 mL DCE were added pyrrolidine 
(1.64 μL, 0.020 mmol) and 2a (13.5 μL, 0.1 mmol) at room temperature. The mixture 
was stirred at room temperature for 15 h. Then the mixture was applied to column 
chromatography directly and eluted with ethyl acetate and hexane to give product 16 in 
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92% yield as yellow oil. E/Z = 33; 1H NMR (300 MHz, CDCl3) δ (ppm) 10.09 (d, J = 7.5 
Hz, 1H), 7.61-7.58 (m, 2H), 7.41-7.23 (m, 5H), 7.04-6.97 (m, 3H), 6.26 (d, J = 7.8 Hz, 
1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 190.9, 167.3, 157.4, 133.0, 131.5, 130.1, 
129.1, 127.6, 123.4, 117.0, 116.7. 
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 Chapter 6 
Asymmetric Desymmetrization of p-Quinols 
 
6.1 Background 
Synthesis of valuable optically active building blocks from simple starting 
materials is highly valuable in organic synthesis. As an important representative scaffold, 
4-hydroxycyclohexanone is present in numerous biologically significant molecules such 
as laggerone A,1 illudin E,2 chinanoxal,3 neoilludin B,4 multistalactone B,5 putralone6 
(Figure 6.1). However, asymmetric synthesis of this target remains challenging due to the 
difficulty in controlling stereoselectivity at 4-OH attached chiral center. 
Figure 6.1 Natural products with 4-hydroxycyclohexanone scaffold 
 
Desymmetrization of readily available and simple prochiral molecules represents a 
viable approach in asymmetric synthesis.7 Asymmetric opening of symmetric epoxides, 
aziridines and anhydrides is achieved with high yields and excellent stereoselectivities.8 
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Desymmetrization via selective alcohol acylations, Wittig reactions, and Tusji-Trost  
reactions have been accomplished.9 Besides, titanium, copper and pig liver esterase 
mediated desymmetrization processes are also developed.10 
Prochiral cyclohexadienones have been subjected to versatile asymmetric 
desymmetrization processes for the synthesis of optically active six-membered ring 
structures. Initially, diastereoselective desymmetrization of cyclohexadienone scaffolds 
via chiral auxiliary approach was developed.11 In 1999, Feringa et al. discovered that 
copper-phosphoramidite catalyst showed remarkably high levels of stereoselectivity in 
the conjugate addition of dialkylzinc reagents (R2Zn) to several 4,4-disubstituted 
cyclohexadienones.12 Feringa and co-workers also carried out an efficient 
enantioselective intramolecular Heck reaction of cyclohexadienones with modular 
TADDOL-based mono-phosphoramidite as chiral ligand.13 Chiral Lewis acids catalyzed 
enantioselective desymmetrization of cyclohexadienone derivatives through asymmetric 
reduction,14 epoxidation15 and Diels–Alder16 reactions were also reported. 
Recently, organocatalytic systems have been proved to be powerful in controlling 
stereoselectivities in the desymmetrization of cyclohexadienones via asymmetric 
Michael,17 oxo-Michael18 and Setter19 reactions. These organocatalytic desymmetrization 
reactions are limited to intramolecular reactions. Intermolecular desymmetrization of p-
quinols via oxo-Michael/Michael addition cascade reactions is also reported.20 
6.2 Research Design 
As a special cyclohexadienone, p-quinols are synthetically useful in the formation 
of chiral 4-hydroxyl cyclohexanones. However, synthesis of medicinally important 
cyclohexanones bearing free 4-OH group via asymmetric desymmetrization of p-quinols 
is challenging due to the difficult in controlling stereoselectivity at 4-position of p-
quinols. 
Scheme 6.1 Design of thiourea catalyzed desymmetrization of p-quinols 
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Chiral ureas/thioureas are found to be powerful organocatalysts for asymmetric 
transformations. We envision that stereoselectivity at 4-position of p-quinols can be 
controlled by the H-bonding interaction formed between the free hydroxyl group and 
thiourea catalyst. It is proposed that bifunctional catalyst 2a can activate the electrophile 
1a with the thiourea unit through H-bonding and the nucleophile PhSH with Brønsted 
base unit simultaneously (Scheme 6.1). It is speculated that PhSH will be deprotonated 
by bifunctional catalyst 2a to afford an ion pair initially. H-bonding can be formed 
between OH group of p-quinol 1a and the deprotonated ion PhS-. It is expected that the 
synergistic interaction can result in high efficiency in terms of reaction yield and 
stereoselectivity for the sulfa-Michael addition reaction. 
Although the OH group at the 4-position of the p-quinol 1a does not take part in the 
catalytic reaction, the functionality may direct the nucleophilic addition in a high stereo-
controlled manner. Therefore, good diastereoselectivity and enantioselectivity can be 
achieved in the desymmetrization process via an intermolecular Michael addition 
reaction. 
6.3 Optimization of Reaction Conditions 
In an exploratory study, desymmetrization of p-quinol 1a by bifunctional catalyst 
2a catalyzed sulfa-Michael addition of PhSH is conducted to give the desired product 3a 
in 64% yield and 0% ee as a single diastereomer (Table 6.1, entry 1). 
Figure 6.2 Chiral urea and thiourea catalysts 
 
Cinchona alkaloid-derived thiourea catalysts are always considered to be superior. 
Indeed, improved but still low ee values are observed when cinchona alkaloid catalyst 2b 
and binaphthyl catalyst 2c are utilized (Table 6.1, entry 2-3). To our delight, the 
enantiomeric excess of 3a is increased dramatically to 85% in the presence of catalyst 2d 
(Table 6.1, entry 4). Investigation (Table 6.1, entry 5-10) of the cinchona alkaloid-
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derived thiourea/urea catalysts reveals that catalyst 2f is more suitable to produce the 
adduct 3a in 79% yield and 90% ee (Table 6.1, entry 6).  
Table 6.1 Optimization of Reaction Conditions[a] 
 
entry Ar ArSH cat. solvent 3 yield (%)[b
]
dr[c] ee
 
(%)[d] 
1 Ph 1 eq 2a toluene 3a 64 >99:1 0
2 Ph 1 eq 2b toluene 3a 74 >99:1 19
3 Ph 1 eq 2c toluene 3a 48 >99:1 40
4 Ph 1 eq 2d toluene 3a 70 >99:1 85
5 Ph 1 eq 2e toluene 3a 73 >99:1 87
6 Ph 1 eq 2f toluene 3a 79 >99:1 90
7 Ph 1 eq 2g toluene 3a 81 >99:1 79
8 Ph 1 eq 2h toluene 3a 78 >99:1 81
9 Ph 1 eq 2i toluene 3a 23 >99:1 66
10 Ph 1 eq 2j toluene 3a 63 >99:1 82
11 Ph 1.2 2f toluene 3a 93 >99:1 91
12 Ph 1.2 2f DCM 3a 87 >99:1 78
13 Ph 1.2 2f CHCl3 3a 67 >99:1 81
14 Ph 1.2 2f hexane 3a 26 >99:1 32
15[e] Ph 1.2 2f toluene 3a 96 >99:1 80
16[f] Ph 1.2 2f toluene 3a 90 >99:1 84
17[g] Ph 1.2 2f toluene 3a 68 >99:1 83
18 2-Me-C6H4 1.2 2f toluene 3ab 99 >99:1 81
19 4-MeO-C6H4 1.2 2f toluene 3ac 99 >99:1 88
20 4-Cl-C6H4 1.2 2f toluene 3ad 75 >99:1 40
[a] See experimental section. [b] Isolated yield. [c] Determined by 1H NMR. [d] 
Determined by HPLC. [e] -20 ºC. [f] 0 ºC. [g] 35 ºC. 
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It is found that the yield of 3a can be increased to 93% with 91% ee when 1.2 eq of 
PhSH is utilized in the desymmetrization process (Table 6.1, entry 11). Screening of 
solvents shows that toluene is optimal for the reaction in terms of yield and ee (Table 6.1, 
entry 11-14). Besides, decreased enantioselectivities are observed when the reaction is 
conducted under low or high temperature (Table 6.1, entry 15-17). Finally, lower 
enantioselectivities are obtained for the transformations employing substituted 
thiophenols with electron-donating or -withdrawing groups (Table 6.1, entry 18-20).  
6.4 Expansion of Substrate Scope 
The desymmetrization of p-quinols by catalyst 2f-mediated sulfa-Michael addition 
reactions of PhSH in toluene under room temperature is carried out accordingly 
employing p-quinols bearing versatile substituents. High yield as 87% and 88% ee are 
obtained for the desymmetrization process with 4-ethyl p-quinol as expected (Table 6.2, 
entry 2). However, only moderate enantioselectivity for Michael product 3c is observed 
when more bulky substrate is utilized (Table 6.2, entry 3). The decreased 
enantioselectivity may be attributed to the weaker H-bonding interaction with the 4-OH 
group (as described in scheme 6.1) resulting from steric effects.  
Similarly, transformations with bulky 4-aryl p-quinols only provide the 
corresponding desymmetrization products with 74-88% ee as single diastereomers (Table 
6.2, entry 4-9). Other 4-alkyl substrates are also applied in the process to furnish products 
3j and 3k in good yields and ee values (Table 6.2, entry 10-11). 
 
 
 
Table 6.2 Substrate scope expansion of organocatalytic sulfa-Michael addition reaction[a] 
 
entry R 3 Yield (%)[b] d.r.[c] ee (%) [d]
1 Me 3a 93 >99:1 91 
2 Et 3b 87 >99:1 88 
3 (CH3)2CH 3c 78 >99:1 71 
4 Ph 3d 85 >99:1 83 
5 4-Me-C6H4 3e 73 >99:1 77 
6 4-F-C6H4 3f 91 >99:1 75 
7 2-F-C6H4 3g 86 >99:1 88 
8 4-Cl-C6H4 3h 79 >99:1 76 
9 4-Br-C6H4 3i 83 >99:1 74 
10 AcOCH2 3j 89 >99:1 83 
11 MeOOC(CH2)2 3k 85 >99:1 80 
[a] Reaction conditions: PhSH (0.12 mmol) in 3 mL toluene was added to a mixture of p-
quinols (0.1 mmol) and the catalyst (10 mol %) in toluene (1.0 mL) in 3 hrs. The reaction 
was stirred at ambient temperature until reaction was complete monitored by TLC. [b] 
Isolated yield. [c] Determined by 1H NMR. [d] Determined by HPLC, absolute 
configuration was not determined. 
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Finally, double sulfa-Michael addition reaction is conducted by the treatment of 1a 
with 2.2 eq of thiophenol (Eq. 1).  Double sulfa-Michael product 4 and meso-5 are 
obtained. The absolute configuration of 4 is determined by crystallographic analysis 
(Figure 6.3). 
Figure 6.3 X-ray structure of product 4 
 
Conclusion 
Intermolecular enantioselective desymmetrization of p-quinols by thiourea catalyst 
mediated sulfa-Michael addition reactions has been developed to furnish the 
corresponding product in good yields and moderate to good enantioselectivities as single 
diastereomers. Application of the process in natural product synthesis will be 
investigated. 
 
Experimental Section 
Preparation and Spectroscopic Data for Substrates 1a-1c 
Substrates 1a-1c are prepared according to reported procedure.21 
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4-Hydroxy-4-methylcyclohexa-2,5-dienone (1a) 
The title compound was obtained in 72% yield as white solid. M. P. 70-71 ºC;
 1
H 
NMR (500 MHz, CDCl3) δ (ppm) 6.89 (d, J = 10.0 Hz, 2H), 6.09 (d, J = 10.0 Hz, 2H), 
3.27 (bs, 1H), 1.47 (s, 3H); 
13
C NMR (125 MHz, CDCl3) δ (ppm) 185.7, 152.7, 126.9, 
67.0, 26.6.  
O
OH  
4-Ethyl-4-hydroxycyclohexa-2,5-dienone (1b) 
The title compound was obtained in 69% yield as light yellow solid. M. P. 58-59 
ºC; 
1
H NMR (300 MHz, CDCl3) δ (ppm) 6.81 (d, J = 9.9 Hz, 2H), 6.18 (d, J = 10.2 Hz, 
2H), 2.73 (s, 1H), 1.81 (q, J = 7.8 Hz, 2H), 0.86 (t, J = 7.5 Hz, 3H); 
13
C NMR (75.5 
MHz, CDCl3) δ (ppm) 186.2, 152.2, 127.8, 70.1, 32.5, 7.7.  
 
4-Hydroxy-4-isopropylcyclohexa-2,5-dienone (1c) 
The title compound was obtained in 65% yield as light brown solid. M. P. 75-76 
ºC;
 1H NMR (CDCl3, 500 MHz) δ (ppm) 6.82 (d, J = 10.0 Hz, 2 H), 6.20 (d, J = 10.5 Hz, 
2 H), 2.46 (s, 1 H), 2.00 (m, J = 7.0 Hz, 1 H), 0.96 (d, J = 7.0 Hz, 6 H); 13C NMR 
(CDCl3, 125 MHz) δ (ppm) 185.8, 150.3, 129.0, 72.3, 36.7, 16.8. 
Preparation and Spectroscopic Data for Substrates 1d-1k 
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Substrates 1d-1k are prepared according to reported procedure.22 
 
1-Hydroxy-[1,1'-biphenyl]-4(1H)-one (1d) 
The title compound was obtained in 41% yield as white solid. M. P. 92-93 ºC;
 1H 
NMR (300 MHz, CDCl3) δ (ppm) 7.48-7.44 (m, 2H), 7.40-7.29 (m, 3H), 6.88 (dt, J = 9.9 
Hz, 3 Hz, 2H), 6.20 (dt, J = 9.9 Hz, 3 Hz, 2H), 2.76 (s, 1H); 13C NMR (75.5 MHz, 
CDCl3) δ (ppm) 186.3, 151.7, 138.6, 128.8, 128.2, 126.3, 125.2, 70.8. 
 
1-Hydroxy-4'-methyl-[1,1'-biphenyl]-4(1H)-one (1e) 
The title compound was obtained in 39% yield as light yellow solid. 1H NMR (300 
MHz, CDCl3) δ (ppm) 7.36 (d, J = 8.4 Hz, 2H), 7.18 (d, J = 8.1 Hz, 2H), 6.89 (d, J = 10.2 
Hz, 2H), 6.18 (d, J = 10.2 Hz, 2H), 3.16 (s, 1H) , 2.35 (s, 3H); 13C NMR (75.5 MHz, 
CDCl3) δ (ppm) 186.0, 151.3, 138.3, 135.7, 129.6, 126.5, 125.2, 70.85, 21.04. 
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4'-Fluoro-1-hydroxy-[1,1'-biphenyl]-4(1H)-one (1f) 
The title compound was obtained in 37% yield as light yellow solid. M. P. 169-170 
ºC;
 1H NMR (300 MHz, CDCl3) δ (ppm) 7.39 (d, J = 8.7 Hz, 2H), 7.30 (d, J = 8.7 Hz, 
2H), 6.84 (d, J = 9.9 Hz, 2H), 6.16 (d, J = 9.9 Hz, 2H), 2.81 (s, 1H); 13C NMR (75.5 
MHz, CDCl3) δ (ppm) 186.3, 151.7, 137.7, 134.1, 128.9, 126.9, 126.4, 70.2. 
 
2'-Fluoro-1-hydroxy-[1,1'-biphenyl]-4(1H)-one (1g) 
The title compound was obtained in 27% yield as light yellow solid. M. P. 103-104 
ºC;
 1H NMR (300 MHz, CDCl3) δ (ppm) 7.72 (td, J = 7.8 Hz, 1.8 Hz, 1H), 7.37-7.29 (m, 
1H), 7.20 (td, J = 7.8 Hz, 1.8 Hz, 1H), 7.04-6.97 (m, 1H), 4.05 (s, 1H); 13C NMR (75.5 
MHz, CDCl3) δ (ppm) 186.1, 161.4, 158.1, 149.2, 130.4, 130.3, 127.3, 127.1, 126.4, 
126.3, 124.7, 124.6, 116.3, 116.1, 68.3.3 
 
4'-Chloro-1-hydroxy-[1,1'-biphenyl]-4(1H)-one (1h) 
The title compound was obtained in 29% yield as white solid. M. P. 124-125 ºC; 1H 
NMR (300 MHz, CDCl3) δ (ppm) 7.48-7.43 (m, 2H), 7.10-7.02 (m, 2H), 6.87 (d, J = 9.9 
Hz, 2H), 6.21 (d, J = 9.9 Hz, 2H), 2.89 (s, 1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 
185.6, 164.3, 161.0, 150.7, 134.4, 127.3, 127.1, 126.9, 116.0, 115.7, 70.6. 
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 4'-Bromo-1-hydroxy-[1,1'-biphenyl]-4(1H)-one (1i) 
The title compound was obtained in 45% yield as yellow solid. M. P. 175-176 ºC;
 
1H NMR (300 MHz, CDCl3) δ (ppm) 7.51 (d, J = 8.7 Hz, 2H), 7.35 (d, J = 8.7 Hz, 2H), 
6.85 (d, J = 9.9 Hz, 2H), 6.23 (d, J = 9.9 Hz, 2H), 2.67 (s, 1H); 13C NMR (75.5 MHz, 
CDCl3) δ (ppm) 185.4, 150.2, 137.7, 132.0, 127.1, 127.1, 122.6, 70.7. 
 
(1-Hydroxy-4-oxocyclohexa-2,5-dien-1-yl)methyl acetate (1j) 
The title compound was obtained in 61% yield as white brown oil. 
1
H NMR (300 
MHz, CDCl3) δ (ppm) 6.90 (d, J = 10.2 Hz, 2H), 6.22 (d, J = 10.2 Hz, 2H), 4.18 (s, 2H), 
4.07 (s, 1H), 2.07 (s, 3H); 
13
C NMR (75.5 MHz, CDCl3) δ (ppm) 185.4, 170.6, 148.3, 
129.1, 68.3, 67.8, 20.6. 
O
OHO
O  
Methyl 3-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)propanoate (1k) 
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The title compound was obtained in 52% yield as yellow oil. 
1
H NMR (300 MHz, 
CDCl3) δ (ppm) 6.85 (d, J = 10.2 Hz, 2H), 6.13 (d, J = 9.9 Hz, 2H), 4.34 (s, 1H), 3.64 (s, 
3H), 2.32 (t, J = 7.5 Hz, 2H), 2.08 (t, J = 8.1 Hz, 2H); 
13
C NMR (75.5 MHz, CDCl3) δ 
(ppm) 185.5, 173.1, 151.1, 127.8, 68.7, 51.6, 34.2, 28.2. 
General Procedure for Sulfa-Michael Addition Reactions 
To a solution of 1a (0.012 g, 0.1 mmol) and catalyst 2f (0.006 g, 0.01 mmol), PhSH 
(12 μL, 0.12 mmol) diluted in 3 mL toluene is added over 3 h under room temperature. 
Solvent is evaporated under reduced pressure. The crude product is purified by flash 
chromatography with ethyl acetate and hexane. 
Physical and Spectroscopic Data for Sulfa-Michael Addition Products 
 
(4S,5R)-4-Hydroxy-4-methyl-5-(phenylthio)cyclohex-2-enone (3a)  
The title compound was obtained in 93% yield as colorless oil. [α]D25 = -99.0 (c = 
1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.49-7.46 (m, 2H), 7.36-7.28 (m, 3H), 
6.76 (dd, J = 10.2 Hz, 1.2 Hz, 1H), 5.95 (d, J = 9.9 Hz, 1H), 3.60 (ddd, J = 6.9 Hz, 4.5 
Hz, 0.9 Hz, 1H), 3.16 (s, 1H), 2.95 (dd, J = 16.8 Hz, 6.9 Hz, 1H), 2.85 (dd, J  = 17.1 Hz, 
4.5 Hz, 1H), 1.59 (s, 3H); 13C NMR (125 MHz, CDCl3) δ (ppm) 196.3, 153.3, 133.8, 
132.8, 129.4, 128.4, 128.1, 69.9, 58.7, 42.3, 26.7. The ee was determined by HPLC on 
Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 70 / 30, 0.5 mL/min-1, λ = 254 nm, tr 
(minor) = 18.25 min, tr (major) = 32.21 min. 
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 (4S,5R)-4-Ethyl-4-hydroxy-5-(phenylthio)cyclohex-2-enone (3b) 
The title compound was obtained in 87% yield as colorless oil. [α]D25 = -113.8 (c = 
1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ (ppm) 7.48 (d, J = 6.0 Hz, 2H), 7.34-7.30 (m, 
3H), 6.78 (d, J = 10.5 Hz, 1H), 6.00 (d, J = 10.5, 1H), 3.67 (t, J = 4.5, 1H), 3.08 (s, 1H), 
2.95 (dd, J = 17.5 Hz, 7.5 Hz, 1H), 2.85 (dd, J = 17.0 Hz, 4.5 Hz, 1H), 2.08-2.01 (m, 1H), 
1.85-1.78 (m, 1H), 0.98 (t, J = 7.5, 3H); 13C NMR (125 MHz, CDCl3) δ (ppm) 196.4, 
153.0, 133.8, 132.9, 129.4, 129.2, 128.1, 72.2, 56.2, 42.1, 32.0, 8.2. The ee was 
determined by HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 70 / 30, 0.5 
mL/min-1, λ = 254 nm, tr (minor) = 17.53 min, tr (major) = 44.13 min. 
 
(4S,5R)-4-Hydroxy-4-isopropyl-5-(phenylthio)cyclohex-2-enone (3c) 
The title compound was obtained in 78% yield as colorless oil. [α]D25 = -108.5 (c = 
1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.49-7.44 (m, 2H), 7.36-7.29 (m, 3H), 
6.88 (dd, J = 10.2 Hz, 1.2 Hz, 1H), 6.01 (d, J = 10.5 Hz, 1H), 3.83-3.79 (m, 1H), 3.05 (d, 
J = 0.6 Hz, 1H), 2.95 (dd, J = 17.1 Hz, 6.0 Hz, 1H), 2.85 (dd, J = 17.4 Hz, 4.5 Hz, 1H), 
2.33-2.24 (m, 1H), 1.11 (d, J = 6.9 Hz, 3H), 0.99 (d, J = 6.6 Hz, 3H); 13C NMR (75.5 
MHz, CDCl3) δ (ppm) 196.2, 152.8, 134.0, 132.9, 129.4, 129.2, 128.1, 73.7, 56.6, 42.0, 
34.8, 17.7, 16.5. The ee was determined by HPLC on Daicel Chiralpak AS-H (25 cm), 
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Hexanes / IPA = 70 / 30, 0.6 mL/min-1, λ = 254 nm, tr (minor) = 16.63 min, tr (major) = 
49.22 min. 
O
OH
SPh
 
(1R,2R)-1-Hydroxy-2-(phenylthio)-2,3-dihydro-[1,1'-biphenyl]-4(1H)-one (3d) 
The title compound was obtained in 85% yield as colorless oil. [α]D25 = -161.4 (c = 
1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.50-7.47 (m, 2H), 7.39-7.31 (m, 8H), 
6.83 (dd, J = 9.9 Hz, 1.2 Hz, 1H), 6.23 (d, J = 10.2 Hz, 1H), 3.87 (s, 1H), 3.82 (ddd, J  = 
6.9 Hz, 4.2 Hz, 1.2 Hz, 1H), 2.89 (dd, J = 16.8 Hz, 7.2 Hz, 1H), 2.73 (dd, J = 16.8 Hz, 
4.2 Hz, 1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 196.5, 151.0, 141.1, 133.4, 133.0, 
129.8, 129.2, 128.6, 128.4, 128.1, 126.0, 74.1, 60.7, 42.0. The ee was determined by 
HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 70 / 30, 0.6 mL/min-1, λ = 
254 nm, tr (minor) = 18.87 min, tr (major) = 31.35 min. 
O
OH
SPh
 
(1R,2R)-1-Hydroxy-4'-methyl-2-(phenylthio)-2,3-dihydro-[1,1'-biphenyl]-4(1H)-one 
(3e) 
The title compound was obtained in 73% yield as light yellow oil. [α]D25 = -142.7 (c 
= 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.37-7.32 (m, 4H), 7.27-7.23 (m, 
3H), 7.15 (d, J = 8.1 Hz, 2H), 6.82 (dd, J = 10.2 Hz, 1.2 Hz, 1H), 6.22 (d, J = 10.2 Hz, 
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1H), 3.83-3.79 (m, 2H), 2.87 (dd, J = 17.1 Hz, 6.9 Hz, 1H), 2.72 (dd, J = 16.8 Hz, 4.2 Hz, 
1H), 2.34 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 196.6, 151.2, 138.2, 138.0, 
133.5, 133.0, 129.7, 129.3, 129.2, 128.0, 125.9, 60.8, 42.0, 21.0. The ee was determined 
by HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 70 / 30, 0.6 mL/min-1, λ = 
254 nm, tr (minor) = 36.57 min, tr (major) = 42.21 min. 
 
(1R,2R)-4'-Fluoro-1-hydroxy-2-(phenylthio)-2,3-dihydro-[1,1'-biphenyl]-4(1H)-one 
(3f) 
The title compound was obtained in 91% yield as light yellow oil. [α]D25 = -93.5 (c 
= 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.41-7.37 (m, 2H), 7.32-7.23 (m, 
7H), 6.78 (dd, J = 10.2 Hz, 0.9 Hz, 1H), 6.23 (d, J = 10.2 Hz, 1H), 3.81 (s, 1H), 3.77 
(ddd, J = 7.8 Hz, 4.2 Hz, 1.2 Hz, 1H), 2.90 (dd, J = 17.1 Hz, 7.8 Hz, 1H), 2.73 (dd, J = 
17.1 Hz, 4.2 Hz, 1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 196.1, 150.3, 139.9, 134.4, 
133.1, 130.1, 129.3, 128.7, 128.2, 127.5, 73.7, 60.4, 41.8. The ee was determined by 
HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 70 / 30, 0.5 mL/min-1, λ = 
254 nm, tr (minor) = 19.28 min, tr (major) = 37.32 min. 
O
OH
SPh
F
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(1R,2R)-2'-Fluoro-1-hydroxy-2-(phenylthio)-2,3-dihydro-[1,1'-biphenyl]-4(1H)-one 
(3g) 
The title compound was obtained in 86% yield as light yellow oil. [α]D25 = -109.4 (c 
= 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.61 (t, J = 4.8 Hz, 1H), 7.26-7.10 
(m, 7H), 6.87-6.80 (m, 2H), 6.17 (d, J = 6.0 Hz, 1H), 3.81 (s, 1H), 4.27 (dd, J = 6.0 Hz, 
2.4 Hz,  1H), 3.59 (s, 1H), 2.96 (dd, J = 7.8 Hz, 6.6 Hz, 1H), 2.73 (dd, J = 10.2 Hz, 2.4 
Hz, 1H); 13C NMR (125 MHz, CDCl3) δ (ppm) 197.0, 150.4, 132.8, 130.3, 130.2, 129.8, 
129.5, 128.9, 128.1, 127.7, 124.1, 116.2, 116.0, 71.7, 55.4, 41.6. The ee was determined 
by HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 70 / 30, 0.5 mL/min-1, λ = 
254 nm, tr (minor) = 20.32 min, tr (major) = 33.62 min. 
 
(1R,2R)-4'-Chloro-1-hydroxy-2-(phenylthio)-2,3-dihydro-[1,1'-biphenyl]-4(1H)-one 
(3h) 
The title compound was obtained in 79% yield as light yellow oil. [α]D25 = -118.9 (c 
= 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.49-7.43 (m, 2H), 7.36-7.25 (m, 
5H), 7.08-7.00 (m, 2H), 6.82 (dd, J = 10.2 Hz, 1.2 Hz, 1H), 6.25 (d, 1H, J = 10.2), 3.85 
(s, 1H), 3.80 (ddd, J = 7.2 Hz, 4.2 Hz, 1.2 Hz, 1H), 2.91 (dd, J = 16.8 Hz, 7.2 Hz, 1H), 
2.75 (dd, J = 16.8 Hz, 4.2 Hz, 1H); 13C NMR (300 MHz, CDCl3) δ (ppm) 196.2, 150.6, 
133.3, 133.0, 130.0, 129.3, 128.2, 127.9, 127.8, 115.6, 115.3, 73.7, 60.8, 41.9. The ee was 
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determined by HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 70 / 30, 0.5 
mL/min-1, λ = 254 nm, tr (minor) = 21.35 min, tr (major) = 51.33 min. 
 
(1R,2R)-4'-Bromo-1-hydroxy-2-(phenylthio)-2,3-dihydro-[1,1'-biphenyl]-4(1H)-one 
(3i) 
The title compound was obtained in 83% yield as light yellow solid. M. P. 112-113 
ºC; [α]D25 = -156.5 (c = 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.47-7.42 (m, 
2H), 7.34-7.23 (m, 5H), 7.05-6.99 (m, 2H), 6.80 (dd, J = 10.2 Hz, 1.2 Hz, 1H), 6.23 (d, J 
= 10.2 Hz, 1H), 3.85 (s, 1H), 3.78 (ddd, J = 7.2 Hz, 4.2 Hz, 1.2 Hz, 1H), 2.89 (dd, J = 
16.8 Hz, 7.5 Hz, 1H), 2.73 (dd, J = 16.8 Hz, 4.2 Hz, 1H); 13C NMR (75.5 MHz, CDCl3) δ 
(ppm) 196.2, 150.3, 140.5, 133.1, 131.6, 130.1, 129.3, 128.2, 127.8, 122.5, 73.7, 60.3, 
41.8. The ee was determined by HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes / 
IPA = 70 / 30, 0.5 mL/min-1, λ = 254 nm, tr (minor) = 19.75 min, tr (major) = 36.69 min. 
 
((1R,6R)-1-hydroxy-4-oxo-6-(phenylthio)cyclohex-2-en-1-yl)methyl acetate (3j) 
The title compound was obtained in 89% yield as light yellow oil. [α]D25 = -95.0 (c 
= 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.49-7.46 (m, 2H), 7.35-7.31 (m, 
3H), 6.78 (d, J = 10.2 Hz, 1H), 4.42 (d, J = 11.4, 1H), 4.22 (d, J = 11.4, 1H), 3.77 (dd, J 
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= 8.7 Hz, 5.1 Hz, 1H), 3.24 (s, 1H), 2.96 (dd, J = 17.1 Hz, 8.7 Hz, 1H), 2.88 (dd, J = 17.1 
Hz, 5.1 Hz, 1H), 2.02 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 196.2, 170.3, 148.4, 
133.2, 132.9, 131.0, 129.4, 128.3, 70.9, 67.0, 52.9, 41.4, 20.6. The ee was determined by 
HPLC on Daicel Chiralpak AS-H (25 cm), Hexanes / IPA = 70 / 30, 0.6 mL/min-1, λ = 
254 nm, tr (minor) = 11.79 min, tr (major) = 14.61 min. 
 
Methyl 3-((1S,6R)-1-hydroxy-4-oxo-6-(phenylthio)cyclohex-2-en-1-yl)propanoate 
(3k) 
The title compound was obtained in 85% yield as light yellow oil. [α]D25 = -34.7 (c 
= 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) δ (ppm) 7.48-7.45 (m, 2H), 7.35-7.27 (m, 
3H), 6.75 (dd, J = 10.5 Hz, 1.5 Hz, 1H), 5.99 (d, J = 10.2 Hz, 1H), 3.68 (s, 3H), 3.63-3.60 
(m, 1H), 3.50 (s, 1H), 2.95-2.92 (m, 2H), 2.58-2.49 (m, 2H), 2.23 (t, J = 7.8 Hz, 2H); 13C 
NMR (75.5 MHz, CDCl3) δ (ppm) 195.7, 173.6, 151.9, 133.6, 132.9, 129.4, 129.2, 128.2, 
71.3, 57.7, 51.9, 42.2, 33.6, 28.5. The ee was determined by HPLC on Daicel Chiralpak 
AS-H (25 cm), Hexanes / IPA = 70 / 30, 0.6 mL/min-1, λ = 254 nm, tr (minor) = 18.49 
min, tr (major) = 22.58 min. 
 
(3R,5R)-4-Hydroxy-4-methyl-3,5-bis(phenylthio)cyclohexanone (4) 
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The title compound was obtained in 42% yield as white solid. 1H NMR (300 MHz, 
CDCl3) δ (ppm) 7.47-7.40 (m, 4H), 7.33-7.25 (m, 6H), 3.76 (t, J = 7.5 Hz, 1H), 3.69 (t, J 
= 4.8 Hz, 1H), 3.09 (dd, J = 15.3 Hz, 4.8 Hz, 1H), 2.81 (s, 1H), 2.72 (d, J = 8.1 Hz, 2H), 
2.40 (dd, J = 15.3 Hz, 4.8 Hz, 1H), 1.67 (s, 3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 
206.1, 133.6, 133.1, 132.8, 132.5, 129.2, 128.0, 127.8, 77.4, 77.0, 76.6, 73.7, 55.9, 54.4, 
44.8, 42.8, 26.4. 
 
(3R,4S,5S)-4-Hydroxy-4-methyl-3,5-bis(phenylthio)cyclohexanone (5) 
The title compound was obtained in 56% yield as colorless oil. 1H NMR (300 MHz, 
CDCl3) δ (ppm) 7.44-7.39 (m, 4H), 7.32-7.25 (m, 6H), 3.26 (dd, J = 13.5 Hz, 4.5 Hz, 
2H), 2.91 (t, J = 14.1 Hz, 2H), 2.60 (dd, J = 13.8 Hz, 3.9 Hz, 2H), 2.47 (s, 1H), 1.71 (s, 
3H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 206.0, 134.0, 132.6, 129.2, 127.8, 73.9, 56.5, 
45.0, 26.9.  
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